Drugs Cosmetics

The Drugs and Cosmetics Act, 1940
------------------------------------------------------------------------
(Act no. 23 of 1940)
INCOMPLETE 9a & Schedules
CONTENTS
Sections Particulars
Introduction
Preamble
1 Short Title, Extent and Commencement.

2 Application of other laws not barred.
3 Definitions.
3A Construction of references to any law not in force or any functionary
not in existence in the State of Jammu and Kashmir.
4 Presumption as to poisonous substances.
5 The Drugs technical advisory board.
6 The central drugs laboratory.
7 The Drugs consultative committee.
7A Section 5 and 7 not to apply to Ayurvedic, Siddha or Unani drugs.
8 Standards of quality.
9 Misbranded drugs.
9A Adulterated drugs.
9B Spurious drugs.
9C Misbranded cosmetics.
9D Spurious cosmetics.
10 Prohibition of import of certain drugs or cosmetics.
10A Power of Central Government to prohibit import of drugs and
cosmetics in public interest.
11 Application of law relating to sea customs and powers of Customs
Officers.
12 Power of Central Government to make rules.
13 Offences.
14 Confiscation.
15 Jurisdiction.
16 Standards of quality
17 Misbranded, drugs.
17A Adulterated drugs.
17B Spurious cosmetics.
17C Misbranded cosmetics
17D Spurious cosmetics
18 Prohibition of manufacture and sale of certain drugs and cosmetics.
18A Disclosure of the name of the manufacturer, etc.
18B Maintenance of records and furnishing of information.
19 Pleas.
20 Government Analysts.
21 Inspectors.
22 Powers of Inspectors.
23 Procedure of Inspectors.
24 Persons bound to disclose place where drugs or cosmetics are
manufactured or kept.
25 Reports of Government Analysts.
26 Purchaser of drug or cosmetic enabled to obtain test or analysis.
26A Powers of Central Government to prohibit manufacture, etc., of drug
and cosmetic in public interest.
27 Penalty for manufacture, sale, etc., of drugs in contravention of this
Chapter.
27A Penalty for manufacture, sale, etc., of cosmetics in contravention of
this Chapter.
28 Penalty for non-disclosure of the name of the manufacturer, etc.
28A Penalty for not keeping documents, etc., and for non-disclosure of
information.
28B Penalty for manufacture, etc., of drugs or cosmetics in contravention
of section 26A.
29 Penalty for use of Government Analyst's report for advertising.
30 Penalty for subsequent offences.
31 Confiscation.
31A Application of provisions of Government departments.
32 Cognizance of offences.
32A Power of Court to implead the manufacturer, etc.
33 Power of Central Government to make rules.
33A Chapter not to apply to Ayurvedic, Siddha or Unani drugs.
33B Application of Chapter IVA.
33C Ayurvedic and Unani Drugs Technical Advisory Board.
33D The Ayurvedic, Siddha and Unani Drugs Consultative Committee.
33E Misbranded drugs.
33EE Adulterated drugs.
33EEA Spurious drugs.
33EEB Regulation of manufacture for sale of Ayurvedic, Siddha and Unani
drugs.
33EEC Prohibition of manufacture and sale of certain Ayurvedic, Siddha and
Unani drugs.
33EED Power of Central Government to prohibit manufacture, etc., of
Ayurvedic, Siddha or Unani drugs in public interest.
33F Government Analysts.
33G Inspectors.
33H Application of provisions of sections 22, 23, 24 and 25.
33I Penalty for manufacture, sale, etc., of Ayurvedic, Siddha or Unani
drug in contravention of this Chapter.
33J Penalty for subsequent offences.
33K Confiscation.
33L Application of provisions to Government departments.
33M Cognizance of offences.
33N Power of Central Government to make rules.
33-O Power to amend First Schedule.
33P Power to give directions.
34 Offences by companies.
34A Offences by Government departments.
34AA Penalty for vexatious search or seizure.
35 Publication of sentences passed under this Act.
36 Magistrate's power to impose enhanced penalties.
36A Certain offences to be tried summarily.
37 Protection of action taken in good faith.
38 Rules to be laid before Parliament.
FIRST SCHEDULE
SECOND SCHEDULE
THE DRUGS AND COSMETICS ACT, 1940
INTRODUCTION
In 1937 a Bill was introduced in the Central Legislative Assembly to give effect to the
recommendations of the Drugs Enquiry Committee to regulate the import of drugs into British
India. This Bill was referred to the Select Committee and the Committee expressed the opinion
that a more comprehensive measure for the uniform control of manufacture and distribution of
drugs as well as of imports was desirable. The Central Government suggested to the Provincial
Governments to ask the Provincial Legislatures to pass resolutions empowering the Central
Legislature to pass on Act for regulating such matters relating to control of drugs as fall within
the Provincial sp here. Provincial Governments got the resolution passed from the Provincial
Legislatures and sent them to the Central Government for getting through the Bill to regulate the
import, manufacture, distribution and sale of Drugs and Cosmetics. Thereupon the Drugs and
Cosmetics Bill was introduced in the Central Legislative Assembly.
STATEMENT OF OBJECTS AND REASONS
1. In order to give effect to the recommendations of the Drugs Enquiry Committee,, in so

far as they relate to matters with which the Central Government is primarily concerned, a Bill to
regulate the import of drugs into British India was introduced in the Legislative Assembly in
1937. The Select Committee appointed by the Legislative Assembly was of the opinion that a
more comprehensive measure providing for the uniform control of the manufacture and
distribution of drugs as well as of import was desirable. The Government of India accordingly
asked Provincial Governments to invite the Provincial Legislatures to pass resolutions under
section 103 of the Government of India Act, 1935, empowering the Central Legislature to pass
an Act for regulating such matters relating to the control of drugs as fall within the Provincial
Legislative List. Such resolutions have now been passed by all Provincial Legislatures.
2. Chapter II of the Bill establishes a Board of Technical Experts to advise the Central
and Provincial Governments on technical matters.
3. Chapter III provides for the control of the import of drugs into British India. The
executive power under this chapter will accordingly be exercised by the Central Government.
4. Chapter IV relates to control of the manufacture, sale and distribution of drugs and
contains the provisions which it is proposed should be enacted in exercise of the powers
conferred by the resolutions under section 103 of the Government of India Act passed by the
Provincial Legislatures. The executive power under Chapter IV will be exercised by the
Provincial Government.
5. The First Schedule prescribes the standards to be complied with by imported drugs and
the Second Schedule prescribes the standards to be complied with the drugs manufactured, sold
or distributed in India. The standards prescribed in the two Schedules are identical. The Central
Government will have power to amend the First Schedule, but power to amend the Second
Schedule will rest with Provincial Government.
6. The Government of India have considered to what extent provision can be made to
secure the maintenance of uniformity in standards and in other important matters in which
uniformity is desirable. They understand that it would be ultra virus of Central Legislature to
assign to any authority other than the Provincial Government's authority conferred by the Bill in
respect of matters falling within the Provincial Legislative field. For this reason it is not possible
to assign the power to fix standards and to make rules to any single authority. In order to assure
that before any action is taken due consideration is given to the desirability of maintaining
uniformity, provision has been made in Chapter VI for a single Technical Advisory Board which
both Central and Provincial Government will be required to consult before modifying the
standards set up by the Bill or before making rules under the Bill.
ACT 23 OF 1940
The Drugs and Cosmetics Bill was passed by the Central Legislative Assembly and it
received the assent of the Governor General on 10th April, 1940 and thus became the Drugs and
Cosmetics Act, 1940 (23 of 1940).
LIST OF AMENDING ACTS AND ADAPTATION ORDERS
1. The Repealing and Amending Act, 1949 (40 of 1949).
2. The Adoption of Laws Order, 1950
3. The part B States (Laws) Act, 1951 (3 of 1951).
4. The Drugs (Amendment) Act, 1955 (11 of 1955).
7. The Drugs and Cosmetics (Amendment) Act, 1964 (13 of 1964).
THE DRUGS AND COSMETICS ACT, 1940
(23 OF 1940)
(Note: For Statement of Object and Reasons, see Gazette of India, 1940, Pt. V, p.34; for the
Report of the Select Committee, see Gazette of India, 1940, Pt. V. p 143)
[10th April, 1940]
Preamble -
An Act to regulate the import, manufacture, distribution and sale of drugs [(Note: Ins. by
Act 21 of 1962, sec.2 (w.e.f. 27.07.1964)) and cosmetics].
WHEREAS it is expedient to regulate the [(Note: Subs. by the A.O. 1950, for certain
words.) import, manufacture, distribution and sale] of drugs [(Note: Subs. by the A.O. 1950, for
certain words.) and cosmetics];
AND WHEREAS the Legislatures of all the Provinces have passed resolutions in terms of
section 103 of the Government of India Act, 1935, in relation to such of the above-mentioned
matters and matters ancillary thereto as are enumerated in List II of the Seventh Schedule to the
said Act;
It is hereby enacted as follows: -
1. Short title, extent and commencement -
(1) This Act may be called the Drugs [(Note: Ins. by Act 21 of 1962, sec.3 (w.e.f. 27.07.1964).
and Cosmetics] Act, 1940.
(2) It extends to the whole of India (Note: The words "except the State of Jammu and
Kashmir" omitted by Act 19 of 1972, sec.2).
(3) It shall come into force at once; but Chapter-III shall take effect only from such date (Note:
1st April, 1947; see Notification No. F.28(10) (3) 45H(I), dated 2nd September, 1946, Gazette of
India, 1946, Pt. I, p.1349. Chapter IV came into force in the State of Delhi, Ajmer and Coorg on
1st April, 1947, see Notification No. F.28(10) (3) 45H(I), Chapter III and IV came into force in
the States of Himachal Pradesh, Bilaspur, Kutch, Bhopal, Tripura, Vindhya Pradesh and
Manipur on 1st April, 1953, vide Notification No. S.R.O. 663, dated 30the March, 1953, Gazette
of India, Pt. II, Sec.3, p.451. Chapter IV came into force in the Union Territory of Dadra and
Nagar Haveli w.e.f. 1st August, 1968, see. Notification No. ADM/Law/117 (74), dated 20th July,
1968, Gazette of India, Pt. III, Sec.3, p.128. The Act is extended to Dadra and Nagar Haveli by
Reg. 6 of 1963, Sec.2 and Sch. I; to Pondicherry by Reg. 7 of 1963, sec.3 and Sch. I; to Goa,
Daman and Diu by Reg.11 of 1963, sec.3 and Sch. and to Laccadive, Minicoy and Amindivi
Islands by Reg. 8 of 1965, sec.3 and Sch.) as the Central Government may, by notification in the
Official Gazette, appoint in this behalf, and Chapter IV shall take effect in a particular State only
from such date as the State Government may, by like notification, appoint in this behalf :
[(Note: Added by Act 19 of 1972, sec.2) Provided that in relation to the State of Jammu and
Kashmir, Chapter III shall take effect only from such date (Note: 24th August, 1974, vide.
Notification No. S.O. 2185, dated 9th August, 1974, Gazette of India, 1974, Pt. II, Sec. 3(ii),
p.2331) after the commencement of the Drugs and Cosmetics (Amendment) Act, 1972, as the
central Government may, by notification in the Official Gazette, appoint in this behalf.]
2. Application of other laws not barred –
The provisions of this Act shall be in addition to, and not in derogation of, the Dangerous Drugs
Act, 1930, and any other law for the time being in force.
3. Definitions –
In this act, unless there is anything repugnant in the subject or context, --
(a) [(Note: Ins. by Act 13 of 1964, sec.2 (w.e.f. 15.09.1964) (Note: Subs. by Act 68 of 1982,
sec.2, for certain words (w.e.f. 01.02.1983). Ayurvedic, Siddha or Unani] drugs" includes all
medicines intended for internal or external use for or in the diagnosis, treatment, mitigation or
prevention of [(Note: Subs. by Act 68 of 1982, sec.3, for certain words (w.e.f. 01.02.1983)
disease or disorder in human beings or animals, and manufactured] exclusively in accordance
with the formulate described in, the authoritative books of [ (Note: Subs. by Act 68 of 1982,
sec.3, for certain words (w.e.f. 01.02.1983) Ayurvedic, Siddha and Unani Tibb system of
medicine], specified in the First Schedule ;]
(aa) [(Note: Original clause (a) was relettered as clause (aa) and substituted by Act 13 of 1964,
sec.2 (w.e.f. 15.09.1964) "the Board" means—
(i) in relation to [ (Note: Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f.
01.02.1983) Ayurvedic, Siddha or Unani] drug, the [ (Note: Subs. by Act 68 of 1982,
sec.3, for certain words (w.e.f. 01.02.1983) Ayurvedic, Siddha and Unani Drugs Technical
Advisory Board] constituted under section 33C ; and
(ii) in relation to any other drug or cosmetic, the Drugs Technical Advisory Board
constituted under-section 5;]
[[(aaa)] (Note: Ins. by Act 21 of 1962, sec.4 (w.e.f. 27.07.1964)) (Note: Relettered by Act 13 of
1964, sec.2 (w.e.f. 15.09.1964)) "cosmetic" means any article intended to be rubbed, poured
sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part
thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and
includes any article intended for use as a component of cosmetic (Note: Certain words omitted
by Act 68 of 1982, sec.3 (w.e.f. 01.02.1983))].
COMMENTS
(i) It is not necessary that the article should be applied to the whole body. If it is applied to
a part of the body and if it beautifies or promotes attractiveness or alters appearance then
also it will be a cosmetic within the meaning of Drugs and Cosmetics Act, 1940; State of
Bombay v. Zahid Hussain, 1975, Mah LJ. 455.
(ii) 'Gandh' and 'nail polish' are 'cosmetics' within the meaning of the Act; State of
Bombay v. Zahid Hussain, 1975 Mah LJ 455.
[(b) (Note: Subs. by Act 11 of 1955, sec.2, for clause (b)) "drug" includes –
[(i) (Note: Subs. by Act 68 of 1982, sec.3, for sub-clause (i) (w.e.f. 01.02.1983)) all
medicines for internal or external use of human beings or animals and all substances
intended to be used for or in the diagnosis, treatment, mitigation prevention of any
disease or disorder in human beings or animals, including preparations applied on
human body for the purpose of repelling insects like mosquitoes; ]
(ii) Such substances (other than food) intended to affect the structure or any function
of the human body or intended to be used for the destruction of [(Note: Subs. by Act
13 of 1964, sec.2, for "vermins" (w.e.f. 15.09.1964) vermin] or insects which cause
disease in human beings or animals, as may be specified from time to time by the
Central Government by notification in the Official Gazette;]
[(iii) (Note: Ins. by Act 68 of 1982, sec.3 (w.e.f. 01.02.1983)) All substances intended
for use as components of a drug including empty gelatin capsules; and
(iv) Such devices intended for internal or external use in the diagnosis, treatment,
mitigation or prevention of disease or disorder in human beings or animals, as may be
specified from time to time by the Central Government by notification in the Official
Gazette, after consultation with the Board;]
COMMENTS
(i). The definition of 'drugs' is an inclusive one. It includes all medicines for external
or internal use of human beings or animals or any substances it ended to be used for
or in the diagnosis, treatment, mitigation or prevention of diseases in human beings
or animals; Langamurti v. State of Orissa, (1973) I CWR 368.
(ii). The appropriate meaning of the expression 'substances' in the section is things;
Chimanlal J. Sheth v. State of Maharashtra, AIR 1963 SC 665.
(iii). Water meant to be used for dissolving other medicines for injection into human
body is 'drug'; R.C. Sundarka v. State of West Bengal, 1971 Cr. LJ 1369: 77 CWN
437.
[(c) (Note: Subs. by Act 13 of 1964, sec.2, for clause (c) (w.e.f. 15.09.1964)) "Government
Analyst" means –
(i) In relation to [(Note: Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f.
01.02.1983)) Ayurvedic, Siddha or Unani] drug, a Government Analyst appointed by the
Central Government or a State Government under section 33F; and
(ii) In relation to any other drug or cosmetic, a Government Analyst appointed by the
Central Government or a State Government under section 20;]
(d) (Note: Clause (d) omitted by Act 19 of 1972, sec.3)
[(e) (Note: Subs. by Act 13 of 1964, sec.2 for clause (e) (w.e.f. 15.09.1964)) "Inspector" means
—
(i) In relation to [ (Note: Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f.
01.02.1983)) Ayurvedic, Siddha or Unani] drug, an Inspector appointed by the Central
Government or a State Government under section 33G; and
(ii) In relation to any other drug or cosmetic, an Inspector appointed by the Central
Government or a State Government under Section 21;]
[(f) (Note: Clause (bbb) ins. by Act 11 of 1955, sec.2) (Note: Clause (bbb) relettered as clause
(f) by Act 35 of 1960, sec.2 (w.e.f. 16.03.1961) "manufacture" in relation to any drug [(Note: Ins.
by Act 21 of 1962, sec.4 (w.e.f. 27.07.1964)) or cosmetic] includes any process or part of a
process for making, altering, ornamenting, finishing, packing, labeling, breaking up or otherwise
treating or adopting any drug [(Note: Ins. by Act 21 of 1962, sec.4 (w.e.f. 27.07.1964)) or
cosmetic] with a view to its [(Note: Subs. by Act 68 of 1982, sec.3, for "sale and distribution"
(w.e.f. 01.02.1983)) sale or distribution] but does not include the compounding or dispensing
[ (Note: Subs. by Act 21 of 1962, sec.4, for "or packing of any drug".) of any drug, or the
packing of any drug or cosmetic,] in the ordinary course of retail business; and "to
manufacture" shall be construed accordingly ;]
(g) (Note: Clauses (c), (d) and (e) relettered as clauses (g), (h) and (i) respectively by Act 35 of
1960, sec.2 (w.e.f. 16.03.1961)). "to import", with its grammatical variations and cognate
expressions means to bring into [(Note: Subs. by Act 3 of 1951, sec.3 and Sch., for "the States".)
India];
[(h) (Note: Clauses (c), (d) and (e) relettered as clauses (g), (h) and (i) respectively by Act 35 of
1960, sec.2 (w.e.f. 16.03.1961)). (Note: Subs. by Act 68 of 1982, sec.3, for clause (h) (w.e.f.
01.02.1983)). "patent or proprietary medicine" means, --
(i) In relation to Ayurvedic, Siddha or Unani Tibb systems of medicine all
formulations containing only such ingredients mentioned in the formulate described
in the authoritative books of Ayurveda, Siddha or Unani Tibb systems of medicine
specified in the First Schedule, but does not include a medicine which is
administered by parental route and also a formulation included in the authoritative
books as specified in clause (a) ;
(ii). In relation to any other systems of medicine, a drug which is a remedy or
prescription presented in a form ready for internal or external administration of
human beings or animals and which is not included in the edition of the Indian
Pharmacopoeia for the time being or any other pharmacopoeia authorised in this
behalf by the Central Government after consultation with the Drugs Technical
Advisory Board constituted under section 5;]
[(I)] (Note: Subs. by Act 11 of 1955, sec.2, for original clause (e)) (Note: Clauses (c), (d) and (e)
relettered as clauses (g), (h) and (i) respectively by Act 35 of 1960, sec.2 (w.e.f. 16.03.1961))
"prescribed" means prescribed by rules made under this Act.]
(f). (Note: Clause (f) ins. by the A.O. 1950 and omitted by Act 3 of 1951, sec.3 and Sch.)
[3A. (Note: Ins. by Act 19 of 1972, sec.4) Constitution of references to any law not in force
or any functionary not in existence in the State of Jammu and Kashmir –
Any reference in this Act to any law which is not in force, or any functionary not in existence, in
the State of Jammu and Kashmir, shall, in relation to that State, be construed as a reference to the
corresponding law in force, or to the corresponding functionary in existence, in that State.]
4. Presumption as to poisonous substances –
Any substance specified as poisonous by rule made under Chapter II or Chapter IV [(Note: Ins.
by Act 13 of 1964, sec.3 (w.e.f. 15.09.1964)) or Chapter IVA] shall be deemed to be a poisonous
substance for the purpose of Chapter III or Chapter IV [(Note: Ins. by Act 13 of 1964, sec.3
(w.e.f. 15.09.1964)) or Chapter IVA], as the case may be.
5. The Drugs Technical Advisory Board –
(1) The Central Government shall, as soon as may be, constitute a Board (to be called the Drugs
Technical Advisory Board) to advise the Central Government and the State Governments on
technical matters arising out of the administration of this Act and to carry out the other functions
assigned to it by this Act.
[(2) (Note: Subs. by Act 13 of 1964, sec.4, for sub-section (2) (w.e.f. 15.09.1964)) The Board
shall consist of the following members, namely,
(i) The Director General of Health Services, ex officio, who shall be Chairman;
(ii) The Drugs Controller, India ex officio;
(iii) The Director of the Central Drugs Laboratory, Calcutta, ex-officio;

(iv) The Director of the Central Research Institute, Kasauli, ex-officio;
(v) The Director of the Indian Veterinary Research Institute, Izatnagar, ex-officio;
(vi) The President of the Medical Council of India, ex-officio;
(vii) The President of the Pharmacy Council of India, ex-officio;
(viii) The Director of the Central Drug Research Institute, Lucknow, ex-officio;
(ix) Two persons to be nominated by the Central Government from among persons
who are in charge of drugs control in the States;
(x) One person, to be elected by the Executive Committee of the Pharmacy Council
of India, from among teachers in pharmacy or pharmaceutical chemistry or
pharmacognosy on the staff of an Indian university or a college affiliated thereto;
(xi) One person, to be elected by the Executive Committee of the Medical Council
of India, from among teachers in medicine or therapeutics on the staff of an Indian
university or a college affiliated thereto;
(xii) One person to be nominated by the Central Government from the

pharmaceutical industry;
(xiii) One pharmacologist to be elected by the Governing Body of the Indian Council
of Medical Research;
(xiv) One person to be elected by the Central Council of the Indian Medical
Association;
(xv) One person to be elected by the Council of the Indian Pharmaceutical

Association;
(xvi) Two persons holding the appointment of Government Analyst under this Act,
to be nominated by the Central Government.]
(3) The nominated and elected members of the Board shall hold office for three years, but shall
be eligible for re-nomination and re-election:
[(Note: Subs. by Act 13 of 1964, sec.4, for the Proviso (w.e.f. 15.09.1964)). Provided that the
person nominated or elected, as the case may be, under clause (ix) or clause (x) or clause (xi) of
clause (xvi) of sub-section (2) shall hold office for so long as he holds the appointment of the
office by virtue of which he was nominated or elected to the Board.]
(4) The Board may, subject to the previous approval of the Central Government, make bye-laws
fixing a quorum and regulating its own procedure and the conduct of all business to be transacted
by it.
(5) The Board may constitute sub-committees and may appoint to such sub-committees for such
periods, not exceeding three years, as it may decide, or temporarily for the consideration of
particular matters, persons who are not members of the Board.
(6) The functions of the Board may be exercised notwithstanding any vacancy therein.
(7) The Central Government shall appoint a person to be Secretary of the Board and shall
provide the Board with such clerical and other staff as the Central Government considers
necessary.
6. The Central Drugs Laboratory –
(1) The Central Government shall, as soon as may be, establish a Central Drugs Laboratory
under the control of a Director to be appointed by the Central Government, to carry out the
functions entrusted to it by this Act or any rules made under this Chapter:
Provided that, if the Central government so prescribes, the functions of the Central Drugs
Laboratory in respect of any drug or class of drugs [(Note: Ins. by Act 21 of 1962, sec.5 (w.e.f.
27.07.1964)) or cosmetic or class of cosmetics] or class of cosmetics] shall be carried out at the
Central Research Institute, Kasauli, or at any other prescribed Laboratory and the functions of
the Director of the Central Drugs Laboratory in respect of such drug or class of drugs [ (Note:
Ins. by Act 21 of 1962, sec.5 (w.e.f. 27.07.1964)) or such cosmetic or class of cosmetics] shall be
exercised by the Director of that Institute or of that other Laboratory, as the case may be.
(2) The Central Government may, after consultation with the Board, make rules prescribing –
(a) The functions of the Central Drugs Laboratory;

(b) (Note: Clause (b) omitted by Act 11 of 1955, sec.4)
(c) (Note: Clause (c) omitted by Act 11 of 1955, sec.4)
(d) The procedure for the submission of the said Laboratory [ (Note: Subs. by Act 13
of 1964, sec.5, for "under Chapter IV" (w.e.f. 15.09.1964)) under Chapter IV or
Chapter IVA] of samples of drugs [ (Note: Ins. by Act 21 of 1962, sec.5 (w.e.f.
27.07.1964)) or cosmetics] for analysis or test, the forms of the Laboratory’s reports
thereon and the fees payable in respect of such reports ;
(e) Such other matters as may be necessary or expedient to enable the said
Laboratory to carry out its functions;
(f) The matters necessary to be prescribed for the purposes of the proviso to sub-
section (1).
7. The Drugs Consultative Committee –
(1) The Central Government may constitute an advisory committee to be called "the Drugs
Consultative Committee" to advise the Central Government, the State Governments and the
Drugs Technical Advisory Board on any matter tending to secure uniformity throughout [(Note:
Ins. by Act 3 of 1951, sec.3 and Sch., for "the States") India] in the administration of this Act.
(2) The Drugs Consultative Committee shall consist of two representatives of the Central
Government to be nominated by that Government and one representative of each State
Government to be nominated by the State Government concerned.
(3) The Drugs Consultative Committee shall meet when required to do so by the Central
Government and shall have power to regulate its own procedure.
[7A. (Note: Ins. by Act 13 of 1964, sec.6 (w.e.f. 15.09.1964)) Section 5 and 7 not to apply to
Ayurvedic, Siddha or Unani drugs. –
Nothing contained in sections 5 and 7 shall apply to [(Note: Subs. by Act 68 of 1982, sec.2, for
certain words (w.e.f. 01.02.1983)). Ayurvedic, Siddha or Unani] drugs.]
(Note: Subs. Act 68 of 1982, sec.4, for the heading under Chapter III (w.e.f. 01.02.1983)).
8. Standards of quality –
[(1)(Note: Subs. Act 21 of 1962, sec.2, for sub-section (1) (w.e.f. 27.07.1964)) For the purposes
of this Chapter, the expression "standard quality’ means –
(a). In relation to a drug, that the drug complies with the standard set out in [(Note: Subs.
by Act 13 of 1964, sec.7, for "the Schedule" (w.e.f. 15.09.1964)) the Second Schedule],
and
(b). In relation to a cosmetic, that the cosmetic complies with such standard as may be
prescribed.]
(2) The Central Government, after consultation with the Board and after giving by notification in
the Official Gazette not less than three months’ notice of its intention so to do, may be a like
notification add to or otherwise amend [(Note: Subs. by Act 13 of 1964, sec.7, for "the
Schedule" (w.e.f. 15.09.1964)) the Second Schedule], for the purposes of this Chapter, and
thereupon [ (Note: Subs. by Act 13 of 1964, sec.7, for "the Schedule" (w.e.f. 15.09.1964))the
Second Schedule] shall be deemed to be amended accordingly.
[9. (Note: Subs. by Act 68 of 1982, sec.5, for section 9 (w.e.f. 01.02.1983)) Misbranded drugs
–
For the purposes of this Chapter, a drug shall be deemed to be misbranded, --
(a) If it is so coloured, coated, powdered or polished that damage is concealed or if

it is made to appear of better or greater therapeutic value than it really is ; or
(b) If it is not labeled in the prescribed manner; or
(c) If its label or contained or anything accompanying the drug bears any statement,
design or device which is false or misleading in any particular.]
9B. Spurious drugs – For the purposes of this Chapter, a drug shall be deemed to be spurious, --
(a) If it is imported under a name which belongs to another drug; or
(b) If it is an imitation of, or is a substitute for, another drug or resembles another

drug in a manner likely to deceive or bears upon it or upon its label or contained the
name of another drug unless it is plainly and conspicuously marked so as to reveal
its true character and its lack of identity with such other drug; or
(c) If the label or container bears the name of an individual or company

purporting to be the manufacturer of the drug, which individual or company is
fictitious or does not exist; or
(d) If it has been substituted wholly or in part by another drug or substance; or
(e) If it purports to be the product of a manufacturer of whom it is only truly a

product.
9C. Misbranded Cosmetics – For the purposes of this Chapter, a cosmetic shall be deemed to
be misbranded –
(a) If it contains a colour which is not prescribed; or
(c) If the label or container or anything accompanying the cosmetic bears any
statement, which is false or misleading in any particular.
9D. Spurious cosmetics – For the purposes of this Chapter, a cosmetic shall be deemed to be
spurious, --
(a) If it is imported under a name which belongs to another cosmetic; or

(b) If it is an imitation of, or is a substitute for, another cosmetic or resembles
another cosmetic in a manner likely to deceive or bears upon it or upon its label or
container the name of another cosmetic, unless it is plainly and conspicuously
marked so as to reveal its true character and its lack of identity with such other
cosmetic; or
(c) If the label or container bears the name of an individual or a company

purporting to be the manufacturer of the cosmetic which individual or company is
fictitious or does not exist; or
(d) If it purports to be the product of a manufacturer of whom it is.]
10. Prohibition of import of certain drugs or cosmetics –
From such date (Note: 1st April, 1947, for clauses (a), (b), (c), (e) and (f) and 1st April, for
clause (d), see Notification No. 18-12-46-D-I, dated 11th February, 1947, Gazette of India, 1947,
Gazette of India, 1947 Pt. I.p.189 as amended by Notification No. F-1-2/48-D(1), dated 29th
September, 1948. 1st April 1953, for the States of Himachal Pradesh, Bilaspur, Kutch, Bhopal,
Tripura, Vindhya Pradesh and Manipur vide Notification No. S.R.O. 666, dated 30th March,
1953, Gazette of India, 1953, Pt. II. Sec.3, p.451) as may be fixed by the Central Government by
notification in the Official Gazette in this behalf, no person shall import –
(a) Any drug [(Note: Ins. by Act 21 of 1962, sec.8 (w.e.f. 27.07.1964)) or cosmetic]
which is not of standard quality;
[(b) (Note: Subs. by Act 21 of 1962, sec.8, for clause (b) (w.e.f. 27.07.1964)) Any
misbranded drug [(Note: Subs. by Act 68 of 1982, sec.7, for "or misbranded cosmetic"
(w.e.f. 01.02.1983)) or misbranded or spurious cosmetics];]
[(bb) (Note: Ins. by Act 13 of 1964, sec.9 (w.e.f. 15.09.1964)) Any [(Note: Subs. by Act
68 of 1982, sec.7, for "adulterated" (w.e.f. 01.02.1983)). adulterated or spurious] drug ;]
(c) Any drug [(Note: Ins. by Act 21 of 1962, sec.8 (w.e.f. 27.07.1964)) or cosmetic]
for the import of which a licence is prescribed, otherwise than under, and in accordance
with, such licence;
[(d) (Note: Subs. by act 11 of 1955, sec.5, for clause (d)) Any patent or proprietary
medicine, unless there is displayed in the prescribed manner on the label or container
thereof [(Note: Subs. by Act 68 of 1982, sec.7, for certain words (w.e.f. 01.02.1983)) the
true formula or list of active ingredients contained in it together with the quantities
thereof];
(e) Any drug which by means of any statement, design or device accompanying it or
by any other means, purports or claims to cure or mitigate any such disease or ailment, or
to have any such other effect, as may be prescribed;
(ee) (Note: Ins. by Act 21 of 1962, sec.8, (w.e.f. 27.07.1964)) Any cosmetic containing
any ingredient, which may render it unsafe or harmful or use under the directions
indicated or recommended;]
(f) Any drug [ (Note: Subs. by Act 21 of 1962, sec.8, for clause (b) (w.e.f. 27.07.1964))
or cosmetic] the import of which is prohibited by rule made under this Chapter.
Provided that nothing in this section shall apply to the import, subject to prescribed
conditions, of small quantities of any drug for the purpose of examination, test or analysis or for
personal use:
Provided further that the Central Government may, after consultation with the Board by
notification in the Official Gazette, permit, subject to any conditions specified in the notification,
the import of any drug or class of drugs not being of standard quality.
(Note: The Explanation omitted by Act 68 of 1982, sec.7 (w.e.f. 01.02.1983))
COMMENTS
Any import to goods, of which the importation is prohibited by law, cannot be a valid
import under the Act. So, goods so imported cannot be treated to be lawfully 'imported goods' ;
S. Mohammed v. Asstt. Collector, Customs, AIR 1970 Cal 134.
[10A. (Note: Ins. by Act 68 of 1982, sec.7 (w.e.f. 01.02.1983)) Power of Central Government
to prohibit import of drugs and cosmetics in public interest –
Without prejudice to any other provision contained in this Chapter, if the Central Government is
satisfied that the use of any drug or cosmetic is likely to involve any risk to human beings or
animals or that any drug does not have the therapeutic value claimed for it or contains
ingredients and in such quantity for which there is no therapeutic justification and that in the
public interest it is necessary or expedient so to do then, that Government may, by notification in
the Official Gazette, prohibit the import of such drug or cosmetic.]
COMMENTS
The Central Government on the basis of the expert advice can indeed adopt an approved
national policy and prescribe an adequate number of formulations, which would on the whole
meet the requirement of the people at large. While laying the guidelines on this score, injurious
drugs should be totally eliminated from the market; Vincent Panikurlangara v. Union of India,
AIR 1987 SC 990.
11. Application of law relating to sea customs and powers of Customs Officers –
(1) The Law for the time being in force relating to sea customs and to goods, the import of which
is prohibited by section 18 of the Sea Customs Act, 1878 (Note: Now see the Customs Act,
1962.) shall, subject to the provisions of section 13 of this Act, apply in respect of drugs [(Note:
Ins. by Act 21 of1962, sec.9 (w.e.f. 27.07.1964)) and cosmetics] the import of which is
prohibited under this Chapter, and officers of Customs and officers empowered under that Act to
perform the duties imposed thereby on a Customs Collector and other officers of Customs, shall
have the same powers in respect of such drugs [(Note: Ins. by Act 21 of 1962, sec.9 (w.e.f.
27.07.1964)) and cosmetics] as they have for the time being in respect of such goods as
aforesaid.
[(2) (Note: Subs. by Act 11 of 1955, sec.6, for sub-section (2)) Without prejudice to the
provisions of sub-section (1), the Customs Collector or any officer of the Government authorised
by the Central Government in this behalf, may detain any imported package which he suspects to
contain any drug [(Note: Ins. by Act 21 of 1962, sec.9 (w.e.f. 27.07.1964)) or cosmetic] the
import of which is prohibited under this Chapter and shall forthwith report such detention to the
Drugs Controller, India, and if necessary, forward the package or sample of any suspected drug
[ (Note: Ins. by Act 21 of 1962, sec.9 (w.e.f. 27.07.1964)) or cosmetic] found therein to the
Central Drugs Laboratory.]
COMMENTS
(i) The tainted goods may be confiscated without proceeding personally against any
person and without coming to a finding as to who was the smuggler; Shermal Jain v.
Collector of Central Excise, AIR 1956 Cal 621.
(ii) Mere unlawful possession of prohibited goods does not lead to conclusion that the
goods had been imported unlawfully. Onus is on the custom authorities to prove the breach
of prohibition order; Kanungo & Co. v. Collector of Customs, AIR 1965 Cal 248: (1965) 1
Cri LJ 547.
12. Power of Central Government to make rules –
(1) The Central Government may, [(Note: Subs. by Act 68 of 1982, sec.9, for "after consultation
with the Board" (w.e.f. 01.02.1983)) after consultation with or on the recommendation of the
Board] and after previous publication by notification in the Official Gazette, make rules for the
purpose of giving effect to the provisions of this Chapter:
[(Note: Ins. by Act 11 of 1955, sec.7) Provided that consultation with the Board may be
dispensed with if the Central Government is of opinion that circumstances have arisen which
render it necessary to make rules without such consultation, but in such a case the Board shall be
consulted within six months of the making of the rules and the Central Government shall take
into consideration any suggestions which the Board may make in relation to the amendment of
the said rules.]
(2) Without prejudice to the generality of the foregoing power, such rules may—
(a) Specify the drugs or classes of drugs [(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f.
27.07.1964)) or cosmetics or classes of cosmetics] for the import of which a licence is
required, [(Note: Subs. by Act 68 of 1982, sec.9, for certain words (w.e.f. 01.02.1983))
and prescribe the form and conditions of such licences, the authority empowered to issue
the same, the fees payable therefor and provide for the cancellation, or suspension of such
licence in any case where any provision of this Chapter or the rules made thereunder is
contravened or any of the conditions subject to which the licence is issued is not
complied with ];
(b) Prescribe the methods of test of test or analysis to be employed in determining
whether a drug [(Note: Ins. by Act 21 of 1962, sec. 10 (w.e.f. 27.07.1964)) or cosmetic] is
of standard quality;
(c) Prescribe, in respect of biological and organometallic compounds, the units or

methods of standardisation;
(cc) (Note: Ins. by Act 13 of 1964, sec. 10 (w.e.f. 15.09.1964)) Prescribe under clause
(d) of [(Note: Subs. by Act 68 of 1982, sec.9 for "section 9B" (w.e.f. 01.02.1983)) section
9A] the colour or colours which a drug may bear or contain for purposes of colouring;]
(d) Specify the diseases or ailments, which an imported drug may not purport or claim
[(Note: Subs. by Act 11 of 1955, sec.7, for "to cure or mitigate" to prevent, cure or
mitigate], and such other effects which such drug may not purport or claim to have;
(e) Prescribe the conditions subject to which small quantities of drugs, the import of
which is otherwise prohibited under this Chapter, may be imported for the purpose of
examination, test or analysis or for personal use ;
(f) Prescribe the places at which drugs [(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f.
27.07.1964)) or cosmetics] may be imported, and prohibit their import at any other place;
(g) Require the date of manufacture and the date of expiry of potency to be clearly and
truly stated on the label or container of any specified imported drug or class of such drug,
and prohibit the import of the said drug or class of drug after the expiry of a specified
period from the date of manufacture;
(h) Regulate the submission by importers, and the securing, of samples of drugs
[(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f. 27.07.1964)) or cosmetics] for examination,
test or analysis by the Central Drugs Laboratory, and prescribe the fees, if any, payable
for such examination, test or analysis;
(i) Prescribe the evidence to be supplied, whether by accompanying documents or

otherwise, of the quality of drugs [(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f.
27.07.1964)) or cosmetics] sought to be imported, the procedure of officers of Customs in
dealing with such evidence, and the manner of storage at places of import of drugs
[(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f. 27.07.1964)) or cosmetics] detained
pending admission;
(j) Provide for the exemption, conditionally or otherwise, from all or any of the
provisions of this Chapter and the rules made thereunder of drugs [(Note: Ins. by Act 21
of 1962, sec.10 (w.e.f. 27.07.1964)) or cosmetics] imported for the purpose only of
transport through, and export from, [(Note: Subs. by Act 3 of 1951, sec.3 and Sch., for
"the States.") India];
(k) Prescribe the conditions to be observed in the packing in bottles, packages or other
containers, of imported drugs [(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f. 27.07.1964))
or cosmetics] [(Note: Ins. by Act 68 of 1982, sec.9 (w.e.f. 01.02.1983)) including the use
of packing material which comes into direct contact with the drugs];
(l) Regulate the mode of labeling drugs [(Note: Ins. by Act 21 of 1962, sec.10 (w.e.f.
27.07.1964)) or cosmetics] imported for sale in packages, and prescribe the matters
which shall or shall not be included in such labels;
(m) Prescribe the maximum proportion of any poisonous substance which may be added
to or contained in any imported drug, prohibit the import of any drug in which that
proportion is exceeded, and specify substances which shall be deemed to be poisonous for
the purposes of this Chapter and the rules made thereunder;
(n) Require that the accepted scientific name of any specified drug shall be displayed in
the prescribed manner on the label or wrapper of any imported, patent or proprietary
medicine containing such drug;
(o) Provide for the exemption, conditionally or otherwise, from all or any of the
provisions of this Chapter or the rules made thereunder of any specified drug or class of
drugs [(Note: Ins. by Act 21 of 1962 (w.e.f. 27.07.1964)) or cosmetics or class of
cosmetics].
13. (Note: Subs. by Act 68 of 1982, sec.10, for section 13 (w.e.f. 01.02.1983)) Offences –
(1) Whoever himself or by any other person on his behalf imports, --
(a) Any drug deemed to be adulterated under section 9A or deemed to be a spurious

drug under section 9B or any spurious cosmetic referred to in section 9D or any
cosmetic of the nature referred to in clause (ee) of section 10 shall be punishable with
imprisonment for a term which may extend to three years and a fine which may extend
to five thousand rupees;
(b) Any drug or cosmetic other than a drug or cosmetic referred to in clause (a), the
import of which is prohibited under section 10, or any rule made under this Chapter,
shall be punishable with imprisonment for a term which may extend to six months, or
with fine which may extend to five hundred rupees, or with both ;
(c) Any drug or cosmetic in contravention of the provisions of any notification
issued under section 10A, shall be punishable with imprisonment for a term which may
extend to three years, or with fine which may extend to five thousand rupees, or with
both.
(2) Whoever having been convicted of an offence –
(a) Under clause (a) or clause (c) of sub-section (1), is again convicted of an offence
under that clause, shall be punishable with imprisonment for a term which may extend
to five years, or with fine which may extend to ten thousand rupees, or with both;
(b) Under clause (b) of sub-section (1), is again convicted of an offence under that
clause, shall be punishable with imprisonment for a term which may extend to one
year, or with fine which may extend to one thousand rupees, or with both.
(3). The punishment provided by this section shall be in addition to any penalty to which the
offender may be liable under the provisions of section 11.]
COMMENTS
Oral evidence can be led to prove previous conviction only if the original judgement of
previous conviction has been lost; City Board Saharampur v. Abdul Waheed, AIR 1959 All 695.
14. Confiscation—
Where any offence punishable under section 13 has been committed, the consignment of the
drugs [(Note: Ins. by Act 21 of 1962, sec.11 (w.e.f. 27.07.1964)) or cosmetics] in respect of
which the offence has been committed shall be liable to confiscation.
15. Jurisdiction –
No Court inferior to that [(Note: Subs. by Act 68 of 1982, sec.11, for certain words (w.e.f.
01.02.1983)) of a Metropolitan Magistrate or of a Judicial Magistrate of the first class] shall try
an offence punishable under section 13.
(Note: Subs. by Act 68 of 1982, sec.12, for "DRUGS" (w.e.f. 01.02.1983)).

16. Standards of quality—
[(1)(Note: Subs. by Act 21 of 1962, sec.12, for sub-section (1) (w.e.f. 27.07.1964)) For the
purposes of this Chapter, the expression "standard quality" means –
(a) In relation to a drug, that the drug complies with the standard set out in [the
Second Schedule], and
(b) In relation to a cosmetic, that the cosmetic complies with such standard as may be
prescribed.]
(2) The [(Note: Subs. by Act 11 of 1955, sec.8, for "State Government".) Central
Government], after consultation with the Board and after giving by notification in the
Official Gazette not less than three months’ notice of its intention so to do, may by a like
notification add to or otherwise amend [(Note: Subs. by Act 13 of 1964, sec.11, for "the
Schedule" (w.e.f. 15.09.1964)) the Second Schedule] for the purposes of this Chapter, and
thereupon [(Note: Subs. by Act 13 of 1964, sec.11, for "the Schedule" (w.e.f. 15.09.1964))
the Second Schedule] shall be deemed to be amended accordingly.
COMMENTS
The standards of qualities are fixed by the Government after due deliberation and after
consulting a committee of competent men, it is for them to give due allowance for probable
errors before fixing a standard. When a standard has been fixed it has to be observed strictly;
State of Kerala v. Vasudevan Nair, 1974 KLT 617 (FB): 1975 Cri LJ 97.
[17. (Note: Subs. by Act 68 of 1982, sec.13, for "section 17, 17A and 17B" (w.e.f. 01.02.1983))
Misbranded drugs –
For the purposes of this Chapter, a drug shall be deemed to be misbranded, -

(c) If its label or container or anything accompanying the drug bears any statement,
design or device which makes any false claim for the drug or which is false or
misleading in any particular.
17A. Adulterated drugs –
For the purposes of this Chapter, a drug shall be deemed to be adulterated, -
(a) If it consists in whole or in part, of any filthy, putrid or decomposed substance; or
(b) If it has been prepared, packed or stored under insanitary conditions whereby it
may have been contaminated with filth or whereby it may have been rendered injurious to
health; or
(c) If its container is composed, in whole or in part, of any poisonous or deleterious

substance which may render the contents injurious to health; or
(d) If it bears or contains, for purposes of colouring only, a colour other than one
which is prescribed; or
(e) If it contains any harmful or toxic substance which may render it injurious to
health; or
(f) If any substance has been mixed therewith so as to reduce its quality or strength.
17B. Spurious drugs –
For the purposes of this Chapter, a drug shall be deemed to be spurious –
(a) If it is manufactured under a name which belongs to another drug; or
(b) If it is an imitation of, or is a substitute for, another drug or resembles another drug
in a manner likely to deceive or bears upon it or upon its label or container the name of
another drug unless it is plainly and conspicuously marked so as to reveal its true
character and its lack of identity with such other drug; or
(c) If the label or container bears the name of an individual or company purporting to
be the manufacturer of the drug, which individual or company is fictitious or does not
exist; or
(d) If it has been substituted wholly or in part by another drug or substance; or
(e) If it purports to be the product of a manufacturer of whom it is not truly a product.

17C. Misbranded cosmetics –
For the purposes of this Chapter, a cosmetic shall be deemed to be misbranded, --
(a) If it contains a colour which is not prescribed; or
(c) If the label or container or anything accompanying the cosmetic bears any
statement which is false or misleading in any particular.
17D. Spurious cosmetics –
For the purposes of this Chapter, a cosmetic shall be deemed to be spurious, --
(a) If it is manufactured under a name which belongs to another cosmetic; or
(b) If it is an imitation of, or a substitute for, another cosmetic or resembles another

cosmetic in a manner likely to deceive or bears upon it or upon its conspicuously marked
so as to reveal its true character and its lack of identity with such other cosmetic; or
(c) If the label or container bears the name of an individual or a company purporting
to be the manufacturer of the cosmetic which individual or company is fictitious or does
not exist ; or
(d) If it purports to be the product of a manufacturer of whom it is not truly a product.]
18. Prohibition of manufacture and sale or certain drugs and cosmetics –
From such date (Note: 1st April, 1947, for sub-clauses (i), (ii), (iv) and (v) of clause (a) and
clause (b) and (c); 1st April, 1949 for sub-clause (iii) of clause (a) in so far as it takes effect in
Delhi, Ajmer and Coorg, see Notification No. 18-12-46-D, II, dated 11th February, 1947, Gazette
of India, 1947, Pt. I, p. 189, as amended by Notification No. F.1-2/48-D(II), dated 29th
September, 1948; 1st April, 1953 for the States of Himachal Pradesh, Bilaspur, Kutch, Bhopal,
Tripura, Vindhya Pradesh and Manipur, vide Notification No. S.R.O. 664, dated 30th March,
1953, Gazette of India, 1953, Pt. II, Sec.3, p.451) as may be fixed by the State Government by
notification in the Official Gazette in this behalf, no person shall himself or by any other person
on his behalf-
(a) [(Note: manufacture for sale or for distribution, or sell, or stock or exhibit or offer
for sale, ] or distribute –
(i) [(Note: Subs. by Act 68 of 1982, sec.14, for clause (i), (ii) and (iia)
(w.e.f. 01.02.1983) Any drug which is not of a standard quality, or is
misbranded, adulterated or spurious;
(ii) Any cosmetic which is not of a standard quality or is misbranded or
spurious; ]
(iii) [(Note: Subs. by Act 11 of 1955, sec.9, for sub-clause (iii)) Any
patent or proprietary medicine, unless there is displayed in the prescribed
manner on the label or container thereof [(Note: Subs. by Act 68 of 1982,
sec.14 the true formula or list of active ingredients contained in it together
with the quantities, thereof];]
(iv) Any drug which by means of any statement design or device
accompanying it or by any other means, purports or claims [(Note: Subs.
by Act 11 of 1955, sec.9, for "to cure or mitigate") to prevent, cure or
mitigate] any such disease or ailment, or to have any such other effect as
may be prescribed;
(v) [(Note: Subs. by Act 21 of 1962, sec.14, for sub-clause (v) (w.e.f.
27.07.1964)) Any cosmetic containing any ingredient, which may render it
unsafe or harmful for use under the directions, indicated or recommended;
(vi) Any drug or cosmetic in contravention of any of the provisions of
this Chapter or any rule made thereunder;]
(b). [(Note: Subs. by Act 68 of 1982, sec.14, for certain words (w.e.f. 01.02.1983)) sell or
stock or exhibit or offer for sale,] or distribute any drug [(Note: Ins. by Act 11 of 1955,
sec.14 (w.e.f. 27.07.1964)) or cosmetic] which has been imported or manufactured in
contravention of any of the provisions of this Act or any rule made thereunder,
(c). (Note: Subs. by Act 68 of 1982, sec.14, for certain words (w.e.f. 01.02.1983))
manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale,] or
distribute any drug [(Note: Ins. by Act 21 of 1962, sec.14 (w.e.f. 27.07.1964)) or
cosmetic], except under, and in accordance with the conditions of, a licence issued for
such purpose under this Chapter.
Provided that nothing in this section shall apply to the manufacture, subject to prescribed
conditions, of small quantities of any drug for the purpose of examination, test or analysis;
Provided further that the [(Note: Subs. by Act 11 of 1955, sec.9, for "State
Government") Central Government] may, after consultation with the Board by notification in
the Official Gazette, permit, subject to any conditions specified in the notification, the [(Note:
Subs. by Act 68 of 1982, sec.14 (w.e.f. 01.02.1983)) manufacture for sale or for distribution,
sale, stocking or exhibiting or offering for sale] or distribution of any drug or class of drugs not
being of standard quality.
(Note: The Explanation omitted by Act 68 of 1982, sec.14 (w.e.f. 01.02.1983)).

COMMENTS
On a reading of section 18A and sub-section (4) of section 23 together, it is clear that out of
the four portions into which the sample has been divided one portion should be sent to the
person, if any, whose name and address and other particulars have been disclosed under section
18A; In re: R. Dayalan, 1978 Cri Lj 1852. (1979) 1 FAC 29.
18A. Disclosure of the name of the manufacturer, etc. –
Every person, not being the manufacturer of a drug or cosmetic or his agent for the distribution
thereof, shall, if so required, disclose to the Inspector the name, address and other particulars of
the person from whom he acquired the drug or cosmetic.]
18B. [Note: Ins. by act 68 of 1982, sec. 15) w.e.f. 01.02.1983)) Maintenance of records and
furnishing of information —
Every person holding a licence under clause (c) of section 18 shall keep and maintain such
records, registers and other documents as may be prescribed and shall furnish to any officer or
authority exercising any power or discharging any function under this Act such information as is
required by such officer or authority for carrying out the purposes of this Act.]
19. Pleas –
(1) Save as hereinafter provided in this section, it shall be no defence in a prosecution under this
Chapter to prove merely that the accused was ignorant of the nature, substance or quality of the
drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] in respect of which
the offence has been committed or of the circumstances of its manufacture or import, or that a
purchaser, having bought only for the purpose of test or analysis, has not been prejudiced by the
sale.
(2) [(Note: Subs. by Act 13 of 1964, sec.15, for certain words (w.e.f. 15.09.1964)) For the
purposes of section 18 a drug shall not be deemed to be misbranded or [(Note: Subs. by Act 68 of
1982, sec.16, for "adulterated" (w.e.f. 01.02.1983) adulterated or spurious] or to be below
standard quality nor shall a cosmetic be deemed to be misbranded or to be below standard
quality] only by reason of the fact that –
(a). There has been added thereto some innocuous substance or ingredient because the
same is required for the manufacture or preparation of the drug [(Note: Ins. by Act 21
of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] as an article of commerce in a state
fit for carriage or consumption, and not to increase the bulk, weight or measure of the
drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] or to
conceal its inferior quality or other defects; or
(aa) (Clauses (aa) inserted by Act 11 of 1955, sec.10, omitted by Act 13 of 1964, sec.
15 (w.e.f. 15.09.1964))
(b) In the process of manufacture, preparation or conveyance some extraneous

substance has unavoidably become intermixed with it; provided that this clause shall
not apply in relation to any sale or distribution of the drug [(Note: Ins. by Act 21 of
1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] occurring after the vendor or distributor
became aware of such intermixture.
[(3) (Note: Subs. by Act 13 of 1964, sec.15, for sub-section (3) (w.e.f. 15.09.1964)) A person, not
being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall not be
liable for a contravention of section 18 if he proves –
(a) That he acquired the drug or cosmetic from a duly licensed manufacturer,
distributor or dealer thereof;
(b) That he did not know and could not, with reasonable diligence, have
ascertained that the drug or cosmetic in any way contravened and remained in the
same state as when he acquired it.]
COMMENTS
All that the prosecution is required to prove in order to establish the contravention of section
18 is the fact that the accused had sold or exhibited for sale the drug which was not of standard
quality or which was a misbranded drug. If the accused want to get rid of the effect of the effect
of the prosecution evidence then it is for them to establish the defences which are available to
them under sub-section (3) of section 19 of the Act; Public Prosecutor v. Hatambhai, AIR 1969
AP 99.
[20. Government Analysts (Note: Subs. by Act 35 of 1960, sec.4, for the original sections 20
and 21 (w.e.f. 16-3-1991))–
(1) The State Government may, by notification in the Official Gazette, appoint such persons as it
thinks fit, having the prescribed qualifications, to be Government Analysts for such areas in the
State and in respect of such drugs or [(Note: Subs. by Act 21 of 1962, sec.16, for " class of
drugs" (w.e.f. 27.07.1964)) classes of drugs or such cosmetics or classes of cosmetics] as may be
specified in the notification.
(2) The Central Government may also, by notification in the Official Gazette, appoint such
persons as it thinks fit, having the prescribed qualifications, to be Government Analysts in
respect of such drugs or [(Note: Subs. by Act 21 of 1962, sec.16, for "class of drugs" (w.e.f.
27.07.1964)) classes of drugs or such cosmetics or classes of cosmetics] as may be specified in
the notification.
(3) Notwithstanding anything contained in sub-section (1) or sub-section (2), neither the
Central Government nor a State Government shall appoint as a Government Analyst any official
not serving under it without the previous consent of the Government under which he is serving.
[(4) (Note: Ins. by Act 68 of 1982, sec.17 (w.e.f. 01.02.1983)) No person who has any
financial interest in the import, manufacture or sale of drugs or cosmetics shall be appointed to
be a Government Analyst under sub-section (1) or sub-section (2) of this section.]
COMMENTS
The Director of Central Laboratory is also a Government Analyst; Ram Shankar Misra v.
State of U.P., (1980) 1 SCC 255.
21. Inspectors –
(1) The Central Government or a State Government may, by notification in the Official Gazette,
appoint such persons as it thinks fit, having the prescribed qualifications, to be Inspectors for
such areas as may be assigned to them by the Central Government or the State Government, as
the case may be.
(2) The powers which may be exercised by an Inspector and the duties which may be
performed by him, the drugs or [(Note: Subs. by Act 21 of 1962, sec.17 for "class of drugs"
(w.e.f. 27.07.1964)) classes of drugs or cosmetics or classes of cosmetics] in relation to which
and the conditions, limitations or restrictions subject to which, such powers and duties may be
exercised or performed shall be such as may be prescribed.
(3) No person who has any financial interest [(Note: Subs. by Act 21 of 1962, sec.17, for "in
the manufacture, import or sale of drugs" (w.e.f. 27.07.1964)) in the import, manufacture or
sale of drugs or cosmetics] shall be appointed to be an Inspector under this section.
(4) Every Inspector shall be deemed to be a public servant within the meaning of section 21 of
the Indian Penal Code, and shall be officially subordinate to such authority [(Note: Ins. by Act 68
of 1982, sec.18 (w.e.f. 01.02.1983)), having the prescribed qualifications,] as the Government
appointing him may specify in this behalf.]
COMMENTS
Judicial notice can be taken of the fact of a person being appointed as Inspector of Drugs
under section 21(1) of the Act when the relevant notification published in the Official Gazette
has been referred to; Ramlagun Singh v. State of Bihar, AIR 1960 Pat. 243.
22. Powers of Inspectors [(Note: Subs. by Act 11 of 1955, sec.11, for section 22). – (1) Subject
to the provisions of section 23 and of any rules made by the Central Government in this behalf,
an Inspector may, within the local limits of the area for which he is appointed, --
(a). [(Note: Subs. by Act 68 of 1982, sec.19, for clauses (a), (b) and (c) (w.e.f.
01.02.1983)). inspect, --
(i). Any premises wherein any drug or cosmetic is being manufactured and
the means employed for standardising and testing the drug or cosmetic;
(ii). Any premises wherein any drug or cosmetic is being sold, or stocked
or exhibited or offered for sale, or distributed;
(b). Take samples of any drug or cosmetic, --
(i) Which is being manufactured or being sold or is stocked or exhibited or

offered for sale, or is being distributed;
(ii) From any person who is in the course of conveying, delivering or preparing
to deliver such drug or cosmetic to a purchaser or a consignee;
(c). At all reasonable times, with such assistance, if any, as he considers necessary, --
(i). Search any person, who, he has reason to believe, has secreted about his
person, any drug or cosmetic in respect of which an offence under this Chapter
has been, or is being, committed; or
(ii). Enter and search any place in which he has reason to believe that an offence
under this Chapter has been, or is being, committed; or
(iii). Stop and search any vehicle, vessel or other conveyance which, he has
reason to believe, is being used for carrying any drug or cosmetic in respect of
which an offence under this Chapter has been, or is being, committed, and order
in writing the person in possession of the drug or cosmetic in respect of which the
offence has been, or is being, committed, not to dispose of any stock of such drug
or cosmetic for a specified period not exceeding twenty days, or, unless the
alleged offence is such that the defect may be removed by the possessor of the
drug or cosmetic, seize the stock of such drug or cosmetic and any substance or
article by means of which the offence has been, or is being committed or which
may be employed for the commission of such offence ;]
[(cc). (Note: Ins. by Act 35 of 1960, sec.5 (w.e.f. 16.03.1961)) examine any record,
register, document or any other material object found [(Note: Subs. by Act 68 of 1982,
sec.19, for certain words (w.e.f. 01.02.1983)) with any person, or in any place, vehicle,
vessel or other conveyance referred to in clause (c)], and seize the same if he has
reason to believe that it may furnish evidence of the commission of an offence
punishable under this Act or the rules made thereunder ;]
[(cca) (Note: Ins. by Act 68 of 1982, sec.19 (w.e.f. 01.02.1983)) Require any person to
produce any record, register, or other document relating to the manufacture for sale or
for distribution, stocking, exhibition for sale, offer for sale or distribution of any drug
or cosmetic in respect of which he has reason to believe that an offence under this
Chapter has been, or is being, or is being, committed ;]
(d) Exercise such other powers as may be necessary for carrying out the purposes of
this Chapter or any rules made thereunder.
(2) The provisions of [(Note: Subs. by Act 68 of 1982, sec.19, for "the Code of Criminal
Procedure, 1898" (w.e.f. 01.02.1983)) the Code of Criminal Procedure, 1973] shall, so far as
may be, apply to any search or seizure under this Chapter as they apply to any search or seizure
made under the authority of a warrant issued under [(Note: Subs. by Act 68 of 1982, sec.19, for
"section 98" (w.e.f. 01.02.1983)) section 94] of the said Code.
[(2A) (Note: Ins. by Act 68 of 1982, sec.19 (w.e.f. 01.02.1983)) Every record, register or other
document seized under clause (cc) or produced under clause (cca) shall be returned to the person,
from whom they were seized or who produce the same, within a period of twenty days of the
date of such seizure or production, as the case may be, after copies thereof or extracts therefrom
certified by that person, in such manner as may be prescribed, have been taken.]
(3) If any person willfully obstructs an Inspector in the exercise of the powers conferred upon
him by or under this Chapter [(Note: Ins. by Act 68 of 1982, sec.19 (w.e.f. 01.02.1983) or
refuses to produce any record, register or other document when so required under clause (cca) of
sub-section (1),] he shall be punishable with imprisonment which may extend to three years, or
with fine, or with both.]
COMMENTS
(i) An order prohibiting disposal of certain drugs is invalid and illegal because it can be
issued only for specified period not exceeding twenty days under section 22(1) (c); B.K.D.
Rajeshwari v. State of Kerala, AIR 1984 Ker 95.
(ii) Since under the Drugs and Cosmetics Act a search or seizure by a Drugs Inspector is
equated to a search and seizure under the authority of a warrant, it is not necessary for a
Drugs Inspector to record his reasons for making a search; Public Prosecutor v. Mahaveer
Prasad, 1972 Cri LJ 1546.
23. Procedure of Inspectors –
(1) Where an Inspector takes any sample of a drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f.
27.07.1964)) or cosmetic] under this Chapter, he shall tender the fair price thereof and may
require a written acknowledgement therefor.
(2) Where the price tendered under sub-section (1) is refused, or where the Inspector seizes
the stock of any drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964) or cosmetic]
under clause (c) of section 22, he shall tender a receipt therefor in the prescribed form.
(3) Where an Inspector takes a sample of a drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f.
27.07.1964) or cosmetic] for the purpose of test or analysis, he shall intimate such purpose in
writing in the prescribed form to the person from whom he takes it and, in the presence of such
person unless he willfully absents himself, shall divide the sample into four portions and
effectively seal and suitably mark the same and permit such person to add his own seal and mark
to all or any of the portions so sealed and marked :
Provided that where the sample is taken from premises whereon the drug [(Note: Ins. by Act
21 of 1962, sec.15 (w.e.f. 27.07.1964) or cosmetic] is being manufactured, it shall be necessary
to divide the sample into three portions only:
Provided further that where the drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f.
27.07.1964) or cosmetic] is made up in containers of small volume, instead of dividing a sample
as aforesaid, the Inspector may, and if the drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f.
27.07.1964)) or cosmetic] be such that it is likely to deteriorate or be otherwise damaged by
exposure shall, take three or four, as the case may be, of the said containers after suitably
marking the same and, where necessary sealing them.
(4) The Inspector shall restore one portion of a sample so divided or one container, as the case
may be, to the person from whom he takes it, and shall retain the remainder and dispose of the
same as follows: -
(i) One portion or container he shall forthwith send to the Government Analyst for
test or analysis;
(ii) The second he shall produce to the Court before which proceedings, if any, are
instituted in respect of the drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f.
27.07.1964)) or cosmetic]; and
[(iii) (Note: Subs. by Act 13 of 1964, sec.16, for clause (iii) (w.e.f. 15.09.1964)) the
third, where taken, he shall send to the person, if any, whose name, address and other
particulars have been disclosed under section 18A.]
(5) Where an Inspector takes any action under clause (c) of section 22, --
(a) He shall use all dispatch in ascertaining whether or not the drug [(Note: Ins. by
Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] contravenes any of the
provisions of section 18 and, if it is ascertained that the drug [(Note: Ins. by Act 21 of
1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] does not so contravene, forthwith
revoke the order passed under the said clause or, as the case may be, taken such action
as may be necessary for the return of the stock-seized;
(b) If he seizes the stock of the drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f.
27.07.1964)) or cosmetic], he shall as soon as may be inform [(Note: Subs. by Act 68
of 1982, sec.20, for "a Magistrate" (w.e.f. 01.02.1983)) a Judicial Magistrate] and take
his orders as to the custody thereof;
(c) Without prejudice to the institution of any prosecution, if the alleged

contravention be such that the defect may be remedied by the possessor of the drug
[(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic], he shall, on
being satisfied that the defect has been so remedied, forthwith revoke his order under
the said clause.
[(6) (Note: Ins. by Act 35 of 1960, sec.6 (w.e.f. 16.03.1961)) Where an Inspector seizes any
record, register, document or any other material object under clause (cc) of sub-section (1) of
section 22, he shall, as soon as may be, inform [(Note: Subs. by Act 68 of 1982, sec.20, for "a
Magistrate" (w.e.f. 01.02.1983)) a Judicial Magistrate] and take his orders as to the custody
thereof.]
COMMENTS
(i) As required by sub-section (4) (iii) of section 23 read with section 18A, it is the duty
of the Drugs Inspector to supply to the person whose particulars are disclosed under
section 18A the third portion of the sample; Agarwal Medical and General Stores v. State
of M.P. AIR 1973 MP 255.
(ii) The validity of the first proviso to section 23(3) cannot be challenged on the ground
that it offends equal protection of law guaranteed by Article 14 of the Constitution as
there is no purpose in having an extra portion in cases where the drug is seized from the
manufacturer himself; T. Babulal v. Drugs Inspector, Madras, 1969 Cri LJ 699: (1970) 1
MLJ 124.
(iii) When the procedure mentioned in section 23 is not followed in a case, the report of
the Government Analyst cannot be treated as conclusive evidence; Dharam Deo Gupta v.
State, AIR 1958 All 865: 1958 Cri LJ 1453.
24. Persons bound to disclose place where drugs or cosmetics are manufactured or kept –
Every person for the time being in charge of any premises whereon any drug [(Note: Ins. by Act
21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] is being manufactured or is kept for sale or
distribution shall, on being required by any Inspector so to do, be legally bound to disclose to the
Inspector the place where the drug [(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or
cosmetic] is being manufactured or is kept, as the case may be.
25. Reports of Government Analysts –
(1) The Government Analyst to whom a sample of any drug [(Note: Ins. by Act 21 of 1962,
sec.15 (w.e.f. 27.07.1964)) or cosmetic] has been submitted for test or analysis under sub-section
(4) of section 23, shall deliver to the Inspector submitting it is signed report in triplicate in the
prescribed form.
(2) The Inspector on receipt thereof shall deliver one copy of the report to the person from
whom the sample was taken [(Note: Subs. by Act 13 of 1964, sec.17, for certain words (w.e.f.
15.09.1964)) and another copy to the person, if any, whose name, address and other particulars
have been disclosed under section 18A], and shall retain the third copy for use in any prosecution
in respect of the sample.
(3) Any document purporting to be a report signed by a Government Analyst under this
Chapter shall be evidence of the facts stated therein, and such evidence shall be conclusive
unless the person from whom the sample was taken [(Note: Subs. by Act 13 of 1964, sec.17, for
"or the said warrantor" (w.e.f. 15.09.1964)) or the person whose name, address and other
particulars have been disclosed under section 18A] has, within twenty-eight days of the receipt
of a copy of the report, notified in writing the Inspector or the Court before which any
proceedings in respect of the sample are pending that he intends to adduce evidence in
contravention of the report.
(4) Unless the sample has already been tested or analysed in the Central Drugs Laboratory,
where a person has under sub-section (3) notified his intention of adducing evidence in
contravention of a Government Analyst’s report, the Court may, of its own motion or in its
discretion at the request either of the complainant or the accused cause the sample of the drug
[(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic] produced before the
Magistrate under sub-section (4) of Section 23 to be sent for test or analysis to the said
Laboratory, which shall make the test or analysis and report in writing signed by, or under the
authority of, the Director of the Central Drugs Laboratory the result thereof, and such report shall
be conclusive evidence of the facts stated therein.
(5) The cost of a test or analysis made by the Central Drugs Laboratory under sub-section (4)
shall be paid by the complainant or accused as the Court shall direct.
COMMENTS
(i) Section 25 does not offend Article 21 of the Constitution as it has sufficiently
protected the basic right of an accused to defend himself; T. Babulal v. Drugs Inspector,
Madras, 1969 Cri LJ 699: (1970) 1 M LJ 124.
(ii) There can be no prejudice to the accused if the Drugs Inspector, instead of sending
the sample to the Government Analyst, sends it to a higher authority namely the Central
Drugs Laboratory; Ram Shankar Misra v. State of U.P., (1980) 1 SCC 255.
(iii) The Public Analyst can analyse the sample himself or cause it to be analysed by
some other person; Bechan v. State, AIR 1966 All 91:1966 Cri LJ 122.
(iv) It is not necessary to mention in the analysis report the methods or technological
processes adopted by the Analyst; Dhian Singh v.Municipal Board, Saharanpur, AIR 1970
SC 318: (1969) 2 SCC 371.
(v) If accused wants to call the Public Analyst as a witness it is his duty to take
appropriate steps; Municipal Corporation of Delhi v. Asa Ram, 1972 Cri LJ 1651 (Del.).
26. Purchaser of drug or cosmetic enabled to obtain test or analysis –
Any person [(Note: Ins. by Act 71 of 1986, sec.2 (w.e.f. 15.09.1987)) or any recognised
consumer association, whether such person is a member of that association or not] shall, on
application in the prescribed manner and on payment of the prescribed fee, be entitled to submit
for test or analysis to a Government Analyst any drug [(Note: Ins. by Act 21 of 1962, sec.15
(w.e.f. 27.07.1964)) or cosmetic] [(Note: Subs. by Act 71 of 1986, sec.2) purchased by him or it]
and to receive a report of such test or analysis signed by the Government Analyst.
Explanation [(Note: Added by Act 71 of 1986, sec.2)– For the purposes of this section and
section 32, "recognised consumer association" means a voluntary consumer association
registered under the Companies Act, 1956 or any other law for the time being in force.]
26A. Powers of Central Government to prohibit manufacture, etc., of drug and cosmetic in
public interest (Note: Ins. by Act 68 of 1982, sec.21 (w.e.f. 01.02.1983)) –
satisfied, that the use of any drug or cosmetic is likely to involve any risk to human beings or
animals or that any drug does not have the therapeutic value claimed or purported to be claimed
for it or contains ingredients and in such quantity for which there is no therapeutic justification
and that in the public interest it is necessary or expedient so to do, then, that Government may,
by notification in the Official Gazette, prohibit the manufacture, sale or distribution of such drug
or cosmetic.]
COMMENTS
The State's obligation of enforce production of qualitative drugs and elimination of

the injurious ones from the market must take within its sweep an obligation to make useful drugs
available at reasonable price so as to be within the common man's reach; Vincent Panikurlangara
v. Union of India; AIR 1987 SC 990.
[27. Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter (Note:
Subs. by Act 68 of 1982, sec.22, for sections 27 and 27A (w.e.f. 01.02.1983))– Whoever, himself
or by any other person on his behalf, manufacturers for sale or for distribution, or sells, or stocks
or exhibits or offers for sale or distributes,--
(a) any drug deemed to be adulterated under section 17A or spurious under section 17B
or which when used by any person for or in the diagnosis, treatment, mitigation, or
prevention of any disease or disorder is likely to cause his death or is likely to cause
such harm on his body as would amount to grievous hurt within the meaning of section
320 of the Indian Penal Code solely on account of such drug being adulterated or
spurious or not of standard quality, as the case may be, shall be punishable with
imprisonment for a term which shall not be less than five years but which may extend
to a term of life and with fine which shall not be less than ten thousand rupees ;
(b) any drug—
(i) deemed to be adulterated under section 17A, but not being a drug referred to in
clause (a), or
(ii) without a valid licence as required under clause © of section 18, shall be
punishable with imprisonment for a term which shall not be less than one year but
which may extend to three years and with fine which shall not be less than five
thousand rupees :
Provided that the Court may, for any adequate and special reasons to be recorded in the
judgment, impose a sentence of imprisonment for a term of less than one year and of fine of less
than five thousand rupees:
(c) any drug deemed to be spurious under section 17B, but not being a drug
referred to in clause (a) shall be punishable with imprisonment for a term which
shall not be less than three years but which may extend to five years and with fine
which shall not be less than five thousand rupees :
Provided that the Court may, for any adequate and special reasons, to be recorded in the
judgement, impose a sentence of imprisonment for a term of less than three years but not less
than one year,
(d) any drug, other than a drug referred to in clause (a) or clause (b) or clause (c),
in contravention of any other provision of this Chapter or any rule made
thereunder, shall be punishable with imprisonment for a term which shall not be
less than one year but which may extend to two years and with fine :
Provided that the Court may for any adequate and special reasons to be recorded in the
judgement impose a sentence of imprisonment for a term of less than one year.
COMMENTS
The absence of any comma after the word "stocks" clearly indicates that the clause "stocks or
exhibits for sale" is one indivisible whole and it contemplates not merely stocking the drugs but
stocking the drugs for the purposes of sale and unless all the ingredients of this category are
satisfied, section 27 of the Act would not be attracted; Mohd Shabir v. State of Maharashtra,
(1979) 1 SCC 568.
27A. Penalty for manufacture, sale, etc., of cosmetics in contravention of this Chapter –
Whoever himself or by any other person on his behalf manufacturers for sale or for distribution,
or sells, or stocks or exhibits or offers for sale –
(i) Any cosmetic deemed to be spurious under section 17C shall be punishable with
imprisonment for a term, which may extend to three years and with fine;
(ii) Any cosmetic other than a cosmetic referred to in clause (I) above in contravention
of any provisions of this Chapter or any rule made thereunder shall be punishable with
imprisonment for a term which may extend to one year or with fine which may extend to
one thousand rupees or with both.]
28. Penalty for non-disclosure of the name of the manufacturer, etc. (Note: Subs. by Act 13
of 1964, sec.19, for section 28 (w.e.f. 15.09.1964)) –
Whoever contravenes the provisions of section 18A [(Note: Ins. by Act 68 of 1982, sec.23 (w.e.f.
01.02.1983)) or section 24] shall be punishable with imprisonment for a term which may extend
to one year, or with fine which may extend to [(Note: Subs. by Act 68 of 1982, sec.23, for "five
hundred rupees" (w.e.f. 01.02.1983)) one thousand rupees,] or with both.]
28A. Penalty for not keeping documents, etc., and for non-disclosure of information (Note:
Sections 28A and 28B Ins. by Act 68 of 1982, sec.24 (w.e.f. 01.02.1983))–
Whoever without reasonable cause or excuse, contravenes the provisions of section18B shall be
punishable with imprisonment for a term which may extend to one year or with fine which may
extend to one thousand rupees or with both.
28B. Penalty for manufacture, etc., of drugs or cosmetics in contravention of section 26A –
Whoever himself or by any other person on his behalf manufacturers or sells or distributes any
drug or cosmetic in contravention of the provisions of any notification issued under section 26A,
shall be punishable with imprisonment for a term which may extend to three years and shall also
be liable to fine which may extend to five thousand rupees.]
29. Penalty for use of Government Analyst’s report for advertising –
Whoever uses any report of a test or analysis made by the Central Drugs Laboratory or by a
Government Analyst, or any extract from such report, for the purpose of advertising any drug
[(Note: Ins. by Act 21 of 1962, sec.15 (w.e.f. 27.07.1964)) or cosmetic], shall be punishable with
fine which may extend to five hundred rupees.
30. Penalty for subsequent offences (Note: Subs. by Act 11 of 1955, sec.14, for section 30)–
[(1) (Note: Subs. by Act 68 of 1982, sec.25, for sub-section (1) (w.e.f. 01.02.1983)) Whoever
having been convicted of an offence, --
(a) Under clause (b) of section 27 is again convicted of an offence under that clause,
shall be punishable with imprisonment for a term which shall not be less than two years but
which may extend to six years and with fine which shall not be less than ten thousand
rupees:
Provided that the Court may, for any adequate and special reasons to be mentioned in the
judgement, impose a sentence of imprisonment for a term of less than two years and of fine of
less than ten thousand rupees:
(b) Under clause (c) of section 27, is again convicted of an offence under that clause
which may extend to four years or with fine which shall not be less than five thousand
rupees, or with both.]
(c) Under clause (d) of section 27, is again convicted of an offence under that clause
which may extend to four years or with fine which shall not be less than five thousand
rupees, or with both.]
[(1A) (Note: Ins. by Act 21 of 1962, sec.20 (w.e.f. 27.07.1964)) Whoever, having been convicted
of an offence under section 27A is again convicted under that section, shall be punishable with
imprisonment for a term which may extend to two years, or with fine which may extend to
[(Note: Subs. by Act 68 of 1982, sec.25, for "one thousand rupees" (w.e.f. 01.02.1983)) two
thousand rupees], or with both.]
(2) Whoever, having been convicted of an offence under (Note: The words and figures "section
28 or" omitted by Act 13 of 1964, sec.20 (w.e.f. 15.09.1964)) section 29 is again convicted of an
offence under the same section, shall be punishable with imprisonment which may extend to
[(Note: Subs. by Act 13 of 1964, sec.20, for "two years") ten years], or with fine, or with both.]
COMMENTS
The first and the second or the subsequent offences must all relate to the branches of the
provisions of this Act; Kamal Singh v. State , 1957 All LJ 9.
31. Confiscation –
[(1)(Note: Re-numbered as sub-section (1) by Act 35 of 1960, sec.9 (w.e.f. 16.03.1961))] Where
any person has been convicted under this Chapter for contravening any such provision of this
Chapter or any rule made thereunder as may be specified by rule made in this behalf, the stock of
the drug [(Note: Ins. by Act 21 of 1962, sec.21 (w.e.f. 27.07.1964)) or cosmetic] in respect of
which the contravention has been made shall be liable to confiscation [(Note: Added by Act 13 of
1964, sec.21 (w.e.f. 15.09.1964)) and if such contravention is in respect of –
[(i) (Note: Subs. by Act 68 of 1982, sec.26, for clause (i) (w.e.f. 01.02.1983)) Manufacture
of any drug deemed to be misbranded under section 17, adulterated under section 17A or
spurious under section 17B ; or]
(ii) [(Note: Subs. by Act 68 of 1982, sec.26, for certain words (w.e.f. 01.02.1983))
manufacture for sale, or for distribution, sale, or stocking or exhibiting or offering for sale,]
or distribution of any drug without a valid licence as required under clause (c) of section 18,
any implements or machinery used in such manufacture, sale or distribution and any
receptacles, packages or coverings in which such drug is contained and the animals,
vehicles, vessels or other conveyances used in carrying such drug shall also be liable to
confiscation].
[(2) (Note: Sub-section (2) ins. by Act 35 of 1960, sec.9, subs. by Act 21 of 1962, sec.21 (w.e.f.
27.07.1964)) Without prejudice to the provisions contained in sub-section (1), where the Court is
satisfied, on the application of an Inspector or otherwise and after such inquiry as may be
necessary that the drug or cosmetic is not of standard quality [(Note: Subs. by Act 13 of 1964,
sec.21, for "or is a misbranded drug" (w.e.f. 15.09.1964)) or is a [(Note: Subs. by Act 68 of 1982,
sec.26, for certain words (w.e.f. 01.02.1983)) misbranded, adulterated or spurious drug or
misbranded or spurious cosmetic,] such drug or, as the case may be, such cosmetic shall be liable
to confiscation.]
31A. Application of provisions to Government departments (Note: Ins. by Act 13 of 1964,

sec.22 (w.e.f. 15.09.1964)) –
The provisions of this Chapter except those contained in section 31 shall apply in relation to the
manufacture, sale or distribution of drugs by any department of Government as they apply in
relation to the manufacture, sale or distribution of drugs by any other person.]
32. Cognizance of offences –
(1) No prosecution under this Chapter shall be instituted except by an Inspector [(Note: Ins. by
Act 71 of 1986, sec.3 (w.e.f. 15.09.1987)) or by the person aggrieved or by a recognised
consumer association whether such person is a member of that association or not.]
(2) No court inferior to that of [(Note: Subs. by Act 68 of 1982, sec.27, for "a Presidency
Magistrate or of a Magistrate of the first class" (w.e.f. 01.02.1983)) a Metropolitan Magistrate
or of a Judicial Magistrate of the first class] shall try an offence punishable under this Chapter.
(3) Nothing contained in this Chapter shall be deemed to prevent any person from being
prosecuted under any other law for any act or omission, which constitutes an offence against this
Chapter.
32A. Power of Court to implead the manufacturer, etc. (Note: Ins. by Act 13 of 1964, sec.23
(w.e.f. 15.09.1964)) –
Where, at any time during the trial of any offence under this Chapter alleged to have been
committed by any person, not being the manufacturer of a drug or cosmetic or his agent for the
distribution thereof, the Court is satisfied, on the evidence adduced before it, that such
manufacturer or agent is also concerned in that offence, then, the Court may, notwithstanding
contained [(Note; Subs. by Act 68 of 1982, sec.28, for "in sub-section (1) of section 351of the
Code of Criminal Procedure, 1898" (w.e.f. 01.02.1983)) in sub-sections (1), (2) and (3) of section
319 of the Code of Criminal Procedure, 1973], proceed against him as though a prosecution had
been instituted against him under section 32.]
COMMENTS
The object to the section seems to be that such a power enables speedy trial of the really
guilty parties; Bhagwandas v. Delhi Admn. (1975) 1 SCC 866; 1975 Cri LJ 1091.
33. Power of Central Government to make rules –
[(Note: Subs. by Act 11 of 1955, sec.15, for sub-section (1)) (1) The Central Government may
[(Note: Subs. by Act 68 of 1982, sec.29, for "after consultation with the Board" (w.e.f.
01.02.1983)) after consultation with, or on the recommendation of, the Board] and after previous
publication by notification in the Official Gazette, make rules for the purpose of giving effect to
the provisions of this Chapter:
Provided that consultation with the Board may be dispensed with if the Central Government
is of opinion that circumstances have arisen which render it necessary to make rules without such
consultation, but in such a case the Board shall be consulted within six months of the making of
the rules and the Central Government shall take into consideration any suggestions which the
Board may make in relation to the amendment of the said rules.]
(2) Without prejudice to the generality of the foregoing power, such rules may –
(a) Provide for the establishment of laboratories for testing and analysing drugs [(Note:
Ins. by Act 21 of 1962, sec.22 (w.e.f. 27.07.1964)) or cosmetics] ;
(b) Prescribe the qualifications and duties of Government Analysts and the qualifications
of Inspectors;
(c) Prescribe the methods of test or analysis to be employed in determining whether a

drug [(Note: Ins. by Act 21 of 1962, sec.22 (w.e.f. 27.07.1964)) or cosmetic] is of standard
quality;
(d) Prescribe, in respect of biological and organometallic compounds, the units or

methods of standardisation;
[(dd) (Note: Ins. by Act 13 of 1964, sec.24 (w.e.f. 15.09.1964)) Prescribe under clause (d)
of [(Note: Subs. by Act 68 of 1982, sec.29, for "section 17B" (w.e.f. 01.02.1983)) section
17A] the colour or colours which a drug may bear or contain for purposes of colouring ;]
(e) Prescribe the forms of licences [(Note: Subs. by Act 68 of 1982, sec.29, for "for the
manufacture for sale" (w.e.f. 01.02.1983)) for the manufacture for sale or for
distribution], for the sale and for the distribution of drugs or any specified drug or class of
drugs [(Note: Ins. by Act 21 of1962, sec.22 (w.e.f. 27.07.1964)) or of cosmetic or any
specified cosmetic or class of cosmetics], the form of application for such licences, the
conditions subject to which such licences may be issued, the authority empowered to issue
the same [(Note: Ins. by Act 68 of 1982, sec.29 (w.e.f. 01.02.1983)) the qualifications of
such authority] and the fees payable therefor [(Note: Ins. by Act 68 of 1982, sec.29 (w.e.f.
01.02.1983)) and provide for the cancellation or suspension of such licences in any case
where any provision of this Chapter or the rules made thereunder is contravened or any of
the conditions subject to which they are issued is not complied with] ;
[(ee) [(Note: Ins. by Act 68 of 1982, sec.29 (w.e.f. 01.02.1983)) Prescribe the records,
registers or other documents to be kept and maintained under section 18B ;
(eea) Prescribed the fees for the inspection )for the purposes of grant or renewal of
licences) of premises, wherein any drug or cosmetic is being or is proposed to be
manufactured ;
(eeb) Prescribe the manner in which copies are to be certified under sub-section (2A) of
section 22;]
(f) Specify the diseases or ailments, which a drug may not purport or claim [(Note:
Subs. by Act 11 of 1955, sec.15, for "to cure or mitigate") to prevent, cure or mitigate] and
such other effects, which a drug may not purport or claim to have;
(g). Prescribe the conditions subject to which small quantities of drugs may be
manufactured for the purpose of examination, test or analysis;
(h) Require the date of manufacture and the date of expiry of potency to be clearly and
truly stated on the label or container of any specified drug or class of drugs, and prohibit the
sale, stocking or exhibition for sale, or distribution of the said drug or class of drugs after
the expiry of a specified period from the date of manufacture or after the expiry of the date
of potency;
(i) Prescribe the conditions to be observed in the packing in bottles, packages, and other
containers of drugs [(Note: Ins. by Act 21 of 1962, sec.22 (w.e.f. 27.07.1964)) or
cosmetics], [(Note: Ins. by Act 68 of 1982, sec.29 (w.e.f. 01.02.1983)) including the use of
packing material which comes into direct contact with the drugs] and prohibit the sale,
stocking or exhibition for sale, or distribution of drugs [(Note: Ins. by Act 21 of 1962,
sec.22 (w.e.f. 27.07.1964)) or cosmetics] packed in contravention of such conditions ;
(j) Regulate the mode of labeling packed drugs [(Note: Ins. by Act 21 of 1962, sec.22
(w.e.f. 27.07.1964)) or cosmetics], and prescribe the matters, which shall or shall not be
included in such labels;
(k) Prescribe the maximum proportion of any poisonous substance which may be added
to or contained in any drug, prohibit the manufacture, sale or stocking or exhibition for sale,
or distribution of any drug in which that proportion is exceeded, and specify substances
which shall be deemed to be poisonous for the purposes of this Chapter and the rules made
thereunder;
(l) Require that the accepted scientific name of any specified drug shall be displayed in
the prescribed manner on the label or wrapper of any patent or proprietary medicine
containing such drug ;
(m) (Note: Clause (m) omitted by Act 13 of 1964, sec.24 (w.e.f. 15.09.1964))
[(n) [(Note: Subs. by Act 35 of 1960, sec.10, for clause (n) (w.e.f. 16.03.1961)) Prescribe
the powers and duties of Inspectors [(Note: Ins. by Act 68 of 1982, sec.29 (w.e.f.
01.02.1983)) and the qualifications of the authority to which such Inspectors shall be
subordinate] and [(Note: Subs. by Act 21 of 1962, sec.22, for "the drugs or class of drugs"
(w.e.f. 27.07.1964)) specify the drugs or classes of drugs or cosmetics or classes of
cosmetics] in relation to which and the conditions, limitations or restrictions subject to
which, such powers and duties may be exercised or performed ;]
(o) Prescribe the forms of report to be given by Government Analysts, and the manner of
application for test or analysis under section 26 and the fees payable therefor;
(p) [(Note: Subs. by Act 13 of 1964, sec.24 for clause (p) (w.e.f. 15.09.1964)) specify the
offences against this Chapter or any rule made thereunder in relation to which an order of
confiscation may be made under section 31; and ]
(q) Provide for the exemption, conditionally or otherwise, from all or any of the
provisions of this Chapter or the rules made thereunder, of any specified drug or class of
drugs [(Note: Ins. by Act 21 of 1962, sec.22 (w.e.f. 27.07.1964)) or cosmetic or class of
cosmetics].
(Note: Sub-section (3) ins. by Act 35 of 1960 and omitted by Act 13 of 1964, sec.24 (w.e.f.
15.09.1964)).
COMMENTS
It was obligatory on the part of the rule making authority to satisfy the Court that it was
necessary in the facts and circumstances of the case to enhance the fees payable for the renewal
of licence in the manner as has been sought to be done; M/s Jaiswal Medical Hall v. Union of
India, AIR 1988 Pat 266.
33A. Chapter not to apply to [Ayurvedic, Siddha or Unani] drugs –
Save as otherwise provided in this Act, nothing contained in this Chapter shall apply to
[Ayurvedic, Siddha or Unani] drugs.]
(Note: Ins. by Act 13 of 1964, sec.26 (w.e.f. 1-2-1969))
(Note: Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f. 01.02.1983))
33B. Application of Chapter IVA –
This Chapter shall apply only to [ (Note: Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f.
01.02.1983)) Ayurvedic, Siddha and Unani] drugs.
33C. Ayurvedic and Unani Drugs Technical Advisory Board –
(1) The Central Government shall, by notification in the Official Gazette and with effect from
such date as may be specified therein, constitute a Board (to be called the [(Note: Subs. by Act
68 of 1982, sec.30, for certain words (w.e.f. 01.02.1983)) Ayurvedic, Siddha and Unani Drugs
Technical Advisory Board] to advise the Central Government and the State Governments on
technical matters arising out of this Chapter and to carry out the other functions assigned to it by
this Chapter.
(2) The Board shall consist of the following members, namely, --
(i) The Director General of Health Services, ex officio;
(ii) The Drugs Controller, India, ex officio,

[(iii) (Note: Subs. by Act 68 of 1982, sec.30, for clause (iii) (w.e.f. 01.02.1983)) The
principal officer dealing with Indian systems of medicine in the Ministry of Health, ex-officio;]
(iv) The Director of the Central Drugs Laboratory, Calcutta, ex-officio;
(v) One person holding the appointment of Government Analyst under section 33F, to
be nominated by the Central Government;
(vi) One Pharmacognocist to be nominated by the Central Government;
(vii) One Photo-chemist to be nominated by the Central Government;
[(viii) (Note: Subs. by Act 68 of 1982, sec.30 for clause (viii) (w.e.f. 01.02.1983)) Four
persons to be nominated by the Central Government, two from amongst the members of
the Ayurvedic Pharmacopoeia Committee, one from amongst the members of Unani
Pharmacopoeia Committee and one from amongst the members of the Siddha
Pharmacopoeia Committee;]
(ix) One teacher in Darvyaguna, and Bhaishajya Kalpana, to be nominated by the

Central Government;
(x) One teacher in ILM-UL-ADVIA and TAKLIS-WA-DAWASAZI, to be nominated

by the Central Government;
[(xi) (Note: Subs. by Act 68 of 1982, sec.30, for clauses (xi) and (xii) (w.e.f.
01.02.1983)) One teacher in Gunapadam to be nominated by the Central Government;
(xii) Three persons, one each to represent the Ayurvedic, Siddha and Unani drug
industry, to be nominated by the Central Government;
(xiii) Three persons, one each from amongst the practitioners of Ayurvedic, Siddha and
Unani Tibb systems of medicine to be nominated by the Central Government.]
(3) The Central Government shall appoint a member of the Board as its Chairman.
(4) The nominated members of the Board shall hold office for three years but shall be eligible
for renomination.
(5) The Board may, subject to the previous approval of the Central Government, make bye-
laws fixing quorum and regulating its own procedure and conduct of all business to be transacted
by it.
(6) The functions of the Board may be exercised notwithstanding any vacancy therein.
(7) The Central Government shall appoint a person to be Secretary of the Board and shall
provide the Board with such clerical and other staff as the Central Government considers
necessary.
33D. The Ayurvedic, Siddha and Unani Drugs Consultative Committee – (Note: Subs. by
Act 68 of 1982, sec.31, for sections 33D and 33E (w.e.f. 01.02.1983))
(1) The Central Government may constitute an Advisory Committee to be called the Ayurvedic,
Siddha and Unani Drugs Consultative Committee to advise the Central Government, the State
Governments and the Ayurvedic, Siddha and Unani Drugs Technical Advisory Board on any
matter for the purpose of securing uniformity throughout India in the administration of this Act
in so far as it relates to Ayurvedic, Siddha or Unani drugs.
(2) The Ayurvedic, Siddha and Unani Drugs Consultative Committee shall consist of two
persons to be nominated by the Central Government as representatives of that Government and
not more than one representative of each State to be nominated by the State Government
concerned.
(3) The Ayurvedic, Siddha and Unani Drugs Consultative Committee shall meet when
required to do so by the Central Government and shall regulate its own procedure.
33E. Misbranded drugs –
For the purposes of this Chapter, an Ayurvedic, Siddha or Unani drug shall be deemed to be
misbranded –

(c) If its label or container or anything accompanying the drug bears any statement,
design or device which makes any false claim for the drug or which is false or
misleading in any particular.
33EE. Adulterated drugs –
adulterated, -
(a) If it consists, in whole or in part, of any filthy, putrid or decomposed substance;

or
(b) It has been prepared, packed or stored under insanitary conditions whereby it
may have been contaminated with filth or whereby it may have been rendered injurious
to health; or
(c) If its container is composed, in whole or in part, of any poisonous or deleterious

substance which may render the contents injurious to health; or
(d) If it bears or contains, for purposes of colouring only, a colour other than one
which is prescribed; or
(e) If it contains any harmful or toxic substance which may render it injurious to
health ; or
(f) If any substance has been mixed therewith so as to reduce its quality or strength.
Explanation – For the purpose of clause (a), a drug shall not be deemed to consist, in whole or
in part, of any decomposed substance only by reason of the fact that such decomposed substance
is the result of any natural decomposition of the drug:
Provided that such decomposition is not due to any negligence on the part of the
manufacturer of the drug or the dealer thereof and that it does not render the drug injurious to
health.
33EEA. Spurious drugs –
spurious –
(a) If it is sold, or offered or exhibited for sale, under a name which belongs to another
drug ; or
(b) If it is an imitation of, or is a substitute for, another drug or resembles another drug
in a manner likely to deceive, or bears upon it or upon its label or container the name of
another drug, unless it is plainly and conspicuously marked so as to reveal its true
character and its lack of identity with such other drug; or
(c) If the label or container bears the name of an individual or company purporting to
be the manufacturer of the drug, which individual or company is fictitious or does not
exist; or
(d) If it has been substituted wholly or in part by any other drug or substance; or
(e) If it purports to be the product of a manufacturer of whom it is not truly a product.

33EEB. Regulation of manufacturer for sale of Ayurvedic, Siddha and Unani drugs –
No person shall manufacture for sale or for distribution any Ayurvedic, Siddha or Unani drug
except in accordance with such standards, if any, as may be prescribed in relation to that drug.
33EEC. Prohibition of manufacture and sale of certain Ayurvedic, Siddha and Unani drugs
–
From such date as the State Government may, by notification in the Official Gazette, specify in
this behalf, no person, either by himself or by any other person on his behalf, shall –
(a) Manufacture for sale or for distribution—
(i). Any misbranded, adulterated or Ayurvedic, siddha or Unani drug;

(ii). Any patent or proprietary medicine, unless there is displayed in the prescribed
manner on the label or container thereof the true list of all the ingredients contained in
it; and
(iii). Any Ayurvedic, Siddha or Unani drug in contravention of any of the provisions of
this Chapter or any rule made thereunder;
(b) Sell, stock or exhibit or offer for sale or offer for sale or distribute any Ayurvedic,
Siddha or Unani drug which has been manufactured in contravention of any of the
provisions of this Act, or any rule made thereunder:
(c) Manufacture for sale or for distribution, any Ayurvedic, Siddha or Unani drug, except
under, and in accordance with the conditions of, a licence issued for such purpose under this
Chapter by the prescribed authority.
Provided that nothing in this section shall apply to Vaidyas and Hakims who manufacture
Ayurvedic, Siddha or Unani drug for the use of their own patients:
Provided further that nothing in this section shall apply to the manufacture, subject to the
prescribed conditions, of small quantities of any Ayurvedic, Siddha or Unani drug for the
purpose of examination, test or analysis.
33EED. Power of Central Government to prohibit manufacture, etc., of Ayurvedic, Siddha

or Unani drugs in public interest –
satisfied on the basis of any evidence or other material available before it that the use of any
Ayurvedic, Siddha or Unani drug is likely to involve any risk to human beings or animals or that
any such drug does not have the therapeutic value claimed or purported to be claimed for it and
that in the public interest it is necessary or expedient so to do then, that Government may, by
notification in the Official Gazette, prohibit the manufacture, sale or distribution of such drug.]
33F. Government Analysts –
appoint such persons as it thinks fit, having the prescribed qualifications to be Government
Analysts for such areas as may be assigned to them by the Central Government or the State
Government, as the case may be.
(2). Notwithstanding anything contained in sub-section (1), neither the Central Government nor a
State Government shall appoint as a Government Analyst any official not serving under it
without the previous consent of the Government under which he is serving.
(3). [(Note: Subs. by Act 68 of 1982, sec.32 (w.e.f. 01.02.1983)) No person who has any
financial interest in the manufacture or sale of any drug shall be appointed to be a Government
Analyst under this section.]
COMMENTS
The opinion of an Analyst, not recognised under section 33F, cannot be relied upon,
whatever may be his qualifications; State v. Rajamani, 1982 Cri LJ (NOC) 71.
33G. Inspectors –
appoint such persons as it thinks fit, having the prescribed qualifications, to be Inspectors for
such areas as may be assigned to them by the Central Government or the State Government as
the case may be.
(2) The powers which may be exercised by an Inspector and the duties which may be performed
by him and the conditions, limitations or restrictions subject to which such powers and duties
may be exercised or performed shall be such as may be prescribed.
(3). No person who has any financial interest in the manufacture or sale of any drug shall be
appointed to be an Inspector under this section.
(4). Every Inspector shall be deemed to be a public servant within the meaning of section 21 of
the Indian Penal Code and shall be officially sub-ordinate to such authority as the Central
Government appointing him may specify in this behalf.
33H. Application of provisions of sections 22, 23, 24 and 25 –
The provisions of sections 22, 23, 24 and 25 and the rules, if any, made thereunder shall, so far as
may be, apply in relation to an Inspector and a Government Analyst appointed under this Chapter
as they apply in relation to an Inspector and a Government Analyst appointed under Chapter IV,
subject to the modification that the references to "drug" in the said sections, shall be construed
as references to [(Note: Subs. by Act 68 of 1982, sec.2 for certain words (w.e.f. 01.02.1983))
Ayurvedic, Siddha or Unani] drug.
33I. Penalty for manufacture, sale, etc., of Ayurvedic, Siddha or Unani drug in
contravention of this Chapter (Note: Subs. by Act 68 of 1982, sec.33, for sections 33I and 33J
(w.e.f. 01.02.1983))–
Whoever himself or by any other person on his behalf—
(1) Manufactures for sale or for distribution –
(a) Any Ayurvedic, Siddha or Unani drug –
(i) Deemed to be adulterated under section 33EE, or
(ii) Without a valid licence as required under clause (c) of section 33EEC, shall
be punishable with imprisonment for a term which may extend to one year and with
fine which shall not be less than two thousand rupees;
(b) Any Ayurvedic, Siddha or Unani drug deemed to be spurious under section
33EEA, shall be punishable with imprisonment for a term which shall not be less than
one year but which may extend to three years and with fine which shall not be less than
five thousand rupees:
judgment, impose a sentence of imprisonment for a term of less than one year and of fine of less
than five thousand rupees; or
(2). Contravenes any other provisions of this Chapter or of section 24 as applied by section 33H
or any rule made under this Chapter, shall be punishable with imprisonment for a term which
may extend to three months and with fine which shall not be less than five hundred rupees.
33J. Penalty for subsequent offences –
Whoever having been convicted of an offences, --
(a) Under clause (a) of sub-section (1) of section 33I is again convicted of an offence
under that clause, shall be punishable with imprisonment for a term which may extend to two
years and with fine which shall not be less than two thousand rupees;
(b) Under clause (b) of sub-section (1) of section 33I is again convicted of an offence
under that clause, shall be punishable with imprisonment for a term which shall not be less than
two years but which may extend to six years and with fine which shall not be less than five
thousand rupees:
judgment, impose a sentence of imprisonment for a term of less than two years and of fine of less
than five thousand rupees;
(c) Under sub-section (2) of section 33I is again convicted of an offence under that sub-
section, shall be punishable with imprisonment for a term which may extend to six months and
with fine which shall not be less than one thousand rupees.]
33K. Confiscation –
Where any person has been convicted under this Chapter, the stock of the [(Note: Subs. by Act
68 of 1982, sec.2, for certain words (w.e.f. 01.02.1983)) Ayurvedic, Siddha or Unani] drug, in
respect of which the contravention has been made, shall be liable to confiscation.
33L. Application of provisions to Government departments –
The provisions of this Chapter except those contained in section 33K shall apply in relation to
the manufacture for sale, sale or distribution of any [(Note: Subs. by Act 68 of 1982, sec.2, for
certain words (w.e.f. 01.02.1983)) Ayurvedic, Siddha or Unani] drug by any department of
Government as they apply in relation to the manufacture for sale, sale or distribution of such
drug by any other person.
33M. Cognizance of offences –
(1). No prosecution under this Chapter shall be instituted except by an Inspector [(Note: Ins. by
Act 68 of 1982, sec.34 (w.e.f. 01.02.1983)) with the previous sanction of the authority specified
under sub-section (4) of section 33G].
(2). No Court inferior to that [(Note: Subs. by Act 68 of 1982, sec.34, for "of a Presidency
Magistrate or of a Magistrate of the first class" (w.e.f. 01.02.1983)) of a Metropolitan Magistrate
or of a Judicial Magistrate of the first class] shall try an offence punishable under this Chapter.
33N. Power of Central Government to make rules –
(1) The Central Government may, [(Note: Subs. by Act 68 of 1982, sec.35, for "after consultation
with the Board" (w.e.f. 01.02.1983)) after consultation with, or on the recommendation of, the
Board] and after previous publication by notification in the Official Gazette, make rules for the
purpose of giving effect to the provisions of this Chapter:
Provided that consultation with the Board may be dispensed with if the Central Government
is of opinion that circumstances have arisen which render it necessary to make rules without such
consultation, but in such case, the Board shall be consulted within six months of the making of
the rules and the Central Government shall take into consideration any suggestions which the
Board may make in relation to the amendment of the said rules.
(2) Without prejudice to the generality of the foregoing power, such rules may –
(a) Provide for the establishment of laboratories for testing and analysing [(Note:
Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f. 01.02.1983)) Ayurvedic,
Siddha or Unani] drugs;
(b) Prescribe the qualifications and duties of Government Analysts and the
qualifications of Inspectors;
(c) Prescribe the methods of test or analysis to be employed in determining whether

any [(Note: Subs. by Act 68 of 1982, sec.2, for certain words (w.e.f. 01.02.1983))
Ayurvedic, Siddha or Unani] drug is labeled with the true list of the ingredients which
it is purported to contain;
(d) Specify any substance as a poisonous substance;
(e) Prescribe the forms of licences for the manufacture for sale of [(Note: Subs. by
Act 68 of 1982, sec.2, for certain words (w.e.f. 01.02.1983)) Ayurvedic, Siddha or
Unani] drugs, [(Note: Ins. by Act 68 of 1982, sec.35 (w.e.f.01.02.1983)) and for sale of
processed Ayurvedic, Siddha or Unani drugs,] the form of application for such
licences, the conditions subject to which such licences may be issued, the authority
empowered to issue the same and the fees payable therefor, [(Note: Ins. by Act 68 of
1982, sec.35 (w.e.f.01.02.1983)) and provide for the cancellation or suspension of such
licences in any case where any provision of this Chapter or rules made thereunder is
contravened or any of the conditions subject to which they are issued is not complied
with];
[(f) (Note: Subs. by Act 68 of 1982, sec.35, for "clause (f)" (w.e.f. 01.02.1983))
Prescribe the conditions to be observed in the packing of Ayurvedic, Siddha and Unani
drugs including the use of packing material which comes into direct contact with the
drugs, regulate the mode of labeling packed drugs and prescribe the matters which
shall or shall not be included in such labels;]
(g) Prescribe the conditions subject to which small quantities of [(Note: Subs. by
Act 68 of 1982, sec.2 for certain words (w.e.f. 01.02.1983)) Ayurvedic, Siddha or
Unani] drugs may be manufactured for the purpose of examination, test or analysis;
and
[(gg) (Note: Ins. by Act 68 of 1982, sec.35 (w.e.f. 01.02.1983)) Prescribe under
clause (d) of section 33EE the colour or colours which an Ayurvedic, Siddha or Unani
drug may bear or contain for purposes of colouring ;
(gga) Prescribe the standards for Ayurvedic, Siddha or Unani drugs under section
33EB;]
(h) Any other matter which is to be or may be prescribed under this Chapter.
33-O. Power to amend First Schedule –
The Central Government, after consultation with the Board and after giving, by notification in
the Official Gazette, not less than three months’ notice of its intention so to do, may, by a like
notification, add to or otherwise amend the First Schedule for the purposes of this Chapter and
thereupon the said Schedule shall be deemed to be amended accordingly.
(Note: Subs. by Act 11 of 1955, sec.16, for section 34)
33P. Power to give directions (Note: Ins. by Act 35 of 1960, sec.11 (w.e.f. 16.03.1961)) (Note:
Section 33A re-numbered as section 33P by Act 13 of 1964, sec.27 (w.e.f. 15.09.1964). –
The Central Government may give such directions to any State Government as may appear to the
Central Government to be necessary for carrying into execution in the State any of the provisions
of this Act or of any rule or order made thereunder.]
34. Offences by companies –
(1) Where an offence under this Act has been committed by a company, every person who at the
time the offence was committed, was in charge of and was responsible to the company for the
conduct of the business of the company, as well as the company shall be deemed to be guilty of
the offence and shall be liable to be proceeded against and punished accordingly:
Provided that nothing contained in this sub-section shall render any such person liable to
any punishment provided in this Act if he proves that the offence was committed without his
knowledge or that he exercised all due diligence to prevent the commission of such offence.
(2) Notwithstanding anything contained in sub-section (1), where an offence under this Act
has been committed by a company and it is proved that the offence has been committed with the
consent or connivance of, or is attributable to any neglect on the part of, any director, manager,
secretary or other officer of the company, such director, manager, secretary or other officer shall
also be deemed to be guilty of that offence and shall be liable to be proceeded against and
punished accordingly.
Explanation – For the purposes of this section –
(a) "company" means a body corporate, and includes a firm or other

association of individuals ; and
(b) "director" in relation to a firm means a partner in the firm.

34A. Offences by Government Departments (Note: Subs. by Act 13 of 1964, sec.28 (w.e.f.
15.09.1964)) –
Where an offence under Chapter IV or Chapter IVA has been committed by any department of
Government, such authority as is specified by the Central Government to be in charge of
manufacture, sale or distribution of drugs or where no authority is specified, the head of the
department, shall be deemed to be guilty of the offence and shall be liable to be proceeded
against and punished accordingly:
Provided that nothing contained in this section shall render any such authority or person
liable to any punishment provided in Chapter IV or Chapter IVA, as the case may be, if such
authority or person proves that the offence was committed without its or his knowledge or that
such authority or person exercised all due diligence to prevent the commission of such offence.]
COMMENTS
A Chemist in a bottling company is an officer of the company; Municipal Corporation of Delhi v.

G. S. Gujaral, 1972 FAC 621 (del).
34AA. Penalty for vexatious search or seizure (Note: Ins. by Act 68 of 1982, sec.36 (w.e.f.
01.02.1983)). —
Any Inspector exercising powers under this Act or the rules made thereunder, who, --
(a) Without reasonable ground of suspicion searches any place, vehicle, vessel or
other conveyance; or
(b) Vexatiously and unnecessarily searches any person; or
(c) Vexatiously and unnecessarily seizes any drug or cosmetic, or any substance or
article, or any record, register, document or other material object; or
(d) Commits, as such Inspector, any other act, to the injury of any person without
having reason to believe that such act is required for the execution of his duty, shall be
punishable with fine which may extend to one thousand rupees.]
35. Publication of sentences passed under this Act –
(1) If any person is convicted of an offence under this Act, [the Court before which the
conviction takes place shall, on application made to it by the Inspector, cause] the offender’s
name, place of residence, the offence of which he has been convicted and the penalty which has
been inflicted upon him to be published at the expense of such person in such newspapers or in
such other manner as the Court may direct.
(2) The expenses of such publication shall be deemed to form part of the costs relating to the
conviction and shall be recoverable in the same manner as those costs are recoverable.
36. Magistrate’s power to impose enhanced penalties –
Notwithstanding anything contained in (Note: The words and figures "section 32 of" omitted by
Act 13 of 1964, sec.29 (w.e.f. 15.09.1964)) [(Note: Subs. by Act 68 of 1982, sec.38, for "the
Code of Criminal Procedure, 1898" (w.e.f. 01.02.1983)) the Code of Criminal Procedure, 1973],
it shall be lawful for [(Note: Subs. by Act 68 of 1982, sec.38, for "any Presidency Magistrate of
any Magistrate of the first class" (w.e.f. 01.02.1983)) any Metropolitan Magistrate or any Judicial
Magistrate of the first class] to pass any sentence authorized by this Act excess of his powers
under (Note: The words and figures "section 32 of" omitted by Act 13 of 1964, sec.29 (w.e.f.
15.09.1964)) the said Code.
36A. Certain offences to be tried summarily (Note: Ins. by Act 68 of 1982, sec.39, (w.e.f.
01.02.1983))–
Notwithstanding anything contained in the Code of Criminal Procedure, 1973, all offences under
this Act, punishable with imprisonment for a term not exceeding three years, other than an
offence under clause (b) of sub-section (1) of section 33I, shall be tried in a summary way by a
Judicial Magistrate of the first class specially empowered in this behalf by the State Government
or by a Metropolitan Magistrate and the provisions of sections 262 to 265 (both inclusive) of the
said Code shall, as far as may be, apply to such trial :
Provided that, in the case of any conviction in a summary trial under this section, it shall be
lawful for the Magistrate to pass a sentence of imprisonment for a term not exceeding one year:
Provided further that when at the commencement of, or in the course of, a summary trial
under this section it appears to the Magistrate that the nature of the case is such that a sentence of
imprisonment for a term exceeding one year may have to be passed or that it is, for any other
reason, undesirable to try the case summarily, the Magistrate shall, after hearing the parties,
record an order to that effect and thereafter recall any witness who has been examined and
proceed to hear or rehear the case in the manner provided by the said Code.]
37. Protection of action taken in good faith –
No suit, prosecution or other legal proceeding shall lie against any person for anything which is
in good faith done or intended to be done under this Act.
COMMENTS
In determining the question of "good faith" the Court should take into account the intellectual
capacity of the accused and the surrounding facts; Muhammad Gul v. Haji Fazley Karim, ILR 56
Cal 1013.
38. Rules to be laid before Parliament (Note: Ins. by Act 13 of 1964, sec.30 (w.e.f.
15.09.1964))–
Every rule made this Act shall be laid as soon as may be after it is made before each House of
Parliament while it is in session for a total period of thirty days which may be comprised in one
session or in two or more successive sessions, [(Note: Subs. by Act 68 of 1982, sec.40, for
certain words (w.e.f. 01.02.1983)) and if, before the expiry of the session immediately following
the session or the successive sessions aforesaid], both Houses agree in making any modification
in the rule or both Houses agree that the rule should not be made, the rule shall thereafter have
effect only in such modified form or be of no effect, as the case may be; so however that any
such modification or annulment shall be without prejudice to the validity of anything previously
done under that rule.]
(Note: Subs. by Act 13 of 1964, sec.31, for the Schedule, the First Schedule came into force
w.e.f. 1-2-1969 and the Second Schedule came into force (w.e.f. 15.09.1964))
THE FIRST SCHEDULE
[See section 3(a)]
(Note: Subs. by Act 68 of 1982, sec.41, for the heading "A. - AYURVEDIC (INCLUDING
SIDDHA) SYSTEM" (w.e.f. 01.02.1983))
[A.—AYURVEDIC AND SIDDHA SYSTEMS]
Ayurveda
Serial No.
Name of bookAYURVEDA
1.
Arogya Kalpadruma
2.
Arka Prakasha
3.
Arya Bhishak
4.
Ashtanga Hridaya
5.
Ashtanga Samgraha
6.
Ayurveda Kalpadruma
7.
Ayurveda Prakasha
8.
Ayurveda Samgraha
9.
Bhaishajya Ratnavali
10.
Bharat Bhaishajya Ratnakara
11.
Bhava Prakasha
12.
Brihat Nighantu Ratnakara
13.
Charaka Samhita
14.
Chakra Datta
15.
Gada Nigraha
16.
Kupi Pakva Rasayana
17.
Nighantu Ratnakara
18.
Rasa Chandanshu
19.
Rasa Raja Sundara
20.
Rasaratna Samuchaya
21.
Rasatantra Sara Siddha Prayoga Samgraha
22.
Rasa Tarangini
23.
Rasa Yoga Sagra
24.
Rasa Yoga Ratnakara
25.
Rasa Yoga Samgraha
26.
Rasendra Sara Samgraha
27.
Rasa Pradipika
28.
Sahasrayoga
29.
Sarvaroga Chikitsa Ratnam
30.
Sarvayoga Chikitsa Ratnam
31.
Siddha Bhaishajya Manimala
32.
Sharangadhara Samhita
33.
Siddha Yoga Samgraha
34.
Sushruta Samhita
35.
Vaidya Chintamani
36.
Vaidyaka Shabda Sindu
37.
Vaidyaka Chikitsa Sara
38.
Vaidya Jiwan
39.
Basava Rajeeyam
40.
Yoga Ratnakara
41.
Yoga Tarangini
42.
Yoga Chintamani
43.
Kashyapasamhita
44.
Bhelasamhita
45.
Vishwanathachikitsa
46.
Vrindachikitsa
47.
Ayurvedachintamani
48.
Abhinavachintamani
49.
Ayurveda-ratnakar
50.
Yogaratnasangraha
51.
Rasamrita
52.
Dravyagunanighantu
53.
Rasamanjari
54.
Bangasena
54-A.
(Note: Ins. by GSR 735(E), dated 28th August, 1987) Aurvedic Formulary of India (Part-I)
54-B.
Aurveda Sara Sangraha.]
SIDDHA
55.
Siddha Vaidya Thirattu
56.
Therayar Maha Karisal
57.
Brahma Muni Karukkadi (300)
58.
Hogar (700)
59.
Pulippani (500)
60.
Agasthiya Paripuranam (400)

61.
Therayar Yamagam
62.
Agasthiya Chenduram (300)
63.
Agasthiyar (1500)
64.
Athmarakshamrutham
65.
Agasthiyar Pin (80)
66.
Agasthiyar Rathna Churukkam

67.
Therayar Karisal (300)
68.
Veeramamuni Nasa Kandam
69.
Agasthiyar (600)
70.
Agasthiyar Kanma Soothiram
71.
18 Siddhar’s Chillarai Kovai
72.
Yogi Vatha Kaviyam
73.
Therayar Tharu
74.
Agasthiyar Vaidya Kaviyam (1500)
75.
Bala Vagadam
76.
Chimittu Rathna (Rathna) Churukkam
77.
Nagamuni (200)
78.
Agasthiyar Chillarai Kovai
79.
Chiktsa Rathna Deepam
80.
Agasthiyar Nayana Vidhi
81.
Yugi Karisal (151)
82.
Therayar Thaila Varkam
83.
Agasthiya Vallathi (600)

84.
(Note: Added by GSR 735(E), dated 28th August, 1987) Siddha Formulary of Unani Medicine
(Part-I)
(Note: Subs. by Act 68 of 1982, sec.41, for the heading "B-UNANI (TIBB)
SYSTEM" (w.e.f. 01.02.1983) [B. –
UNANI TIBB SYSTEM]
1.
Karabadin Qadri
2.
Karabadin Kabir
3.
Karabadin Azam
4.
Iiaj-ul-amraz
5.
Al Karabadin
6.
Biaz Kabir Vol.II
7.
Karabadin Jadid
8.
Kitab-ul-Taklis
9.
Sanat-ul-Taklis
10.
Mifta-ul-Khazain
11.
Madan-ul-Aksir
12.
Makhzan-ul-Murabhat
13.
(Note: Added by GSR 735(E), dated 28th August, 1987) National Formulary of Unani Medicine
(Part-I)
THE SECOND SCHEDULE
(See sections 8 and 16)
STANDARDS TO BE COMPLIED WITH BY IMPORTED DRUGS AND BY DRUGS

MANUFACTURED FOR SALE, SOLD, STOCKED OR EXHIBITED FOR SALE FOR
DISTRIBUTED
Serial No.
Class of drug
Standard to be complied with
1.Patent or proprietary medicines [(Note: Ins. by Notification No. S.O. 887, dated 19th March,
1966, Gazette of India, Pt. II, Sec.3(ii), p.819) other than Homoeopathic medicines]. The formula
or list of ingredients displayed in the prescribed manner on the label or container and such other
standards as may be prescribed.2.Substances commonly known as vaccines, sera, toxine, toxoids,
antitoxins, and antigens and biological products of such nature.The standards maintained at the
International Laboratory for Biological Standards, Stantans Seruminstitut, Copenhagen, and such
further standards of strength, quality and purity as may be prescribed.3.
Vitamins, hormones and analogous products.
The standards maintained at the International Laboratory for Biological Standards, National
Institute for Medical Research, London, and such further standards of strength, quality and purity
as may be prescribed.4.Substances (other than food) intended to affect the structure or any
function of the human body or intended to be used for the destruction of vermin or insects which
cause disease in human beings or animals.Such standards as may be prescribed.4-A.(Note: Subs.
by Notification No. S.O. 820, dated 6th June, 1978, Gazette of India, Pt. II, Sec. 3(ii), p.1471)
Homoeopathic Medicines: (a) Drugs included in the Homoeopathic Pharmacopoeia of India.
Standards of identity, purity and strength specified in the edition of the Homoeopathic
Pharmacopoeia of India for the time being and such other standards as may be prescribed.(b)
Drugs not included in the Homoeopathic Pharmacopoeia of India but which are included in the
Homoeopathic Pharmacopoeia of United States of America or the United Kingdom or the
German Homoeopathic Pharmacopoeia.Standards of identity, purity and strength prescribed for
the drugs in the edition of such Pharmacopoeia for the time being in which they are given and
such other standards as may be prescribed.(c) Drugs not included in the Homoeopathic
Pharmacopoeia of India or the United States of America, or the United Kingdom or the German
Homoeopathic Pharmacopoeia.The formula or list of ingredients displayed in the prescribed
manner on the lable of the container and such other standards as may be prescribed by the
Central Government].5.[(Note: Subs. by Notification No. S.O. 885, dated 4th August, 1973,
Gazette of India, Pt. II, Sec. 3(ii), p.1643.) Other drugs: (a) Drugs included in the Indian
Pharmacopoeia.
Standards of identity, purity and strength specified in the edition of the Indian Pharmacopoeia for
the time being and such other standards as may be prescribed.
In case the standards of identity, purity and strength for drugs are not specified in the edition of
the Indian Pharmacopoeia for the time being in force but are specified in the edition of the Indian
Pharmacopoeia immediately preceding, the standards of identity, purity and strength shall be
those occurring in such immediately preceding edition of the Indian Pharmacopoeia and such
other standards as may be prescribed.
(b) Drugs not included in the Indian Pharmacopoeia but which are included in the official
Pharmacopoeia of any other country.
Standards of identity, purity and strength specified for drugs in the edition of such offcial
Pharmacopoeia of any other country for the time being in force and such other standards as may
be prescribed.
In case the standards of identity, purity and strength for drugs are not specified in the edition of
such official Pharmacopoeia for the time being in force but are specified inthe edition
immediately strength shall be those occurring in such immediately preceding edition of such
official Pharmacopoeia and such other standards as may be prescribed.]

Drugs Cosmetics

Uploaded by

Copyright:

Available Formats

Drugs Cosmetics

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Drugs Cosmetics

Uploaded by

Copyright:

Available Formats

The Drugs and Cosmetics Act, 1940

1 Short Title, Extent and Commencement.

STATEMENT OF OBJECTS AND REASONS

1. In order to give effect to the recommendations of the Drugs Enquiry Committee,, in so

LIST OF AMENDING ACTS AND ADAPTATION ORDERS

1. The Repealing and Amending Act, 1949 (40 of 1949).

2. The Adoption of Laws Order, 1950

3. The part B States (Laws) Act, 1951 (3 of 1951).

4. The Drugs (Amendment) Act, 1955 (11 of 1955).

5. The Drugs (Amendment) Act, 1960 (35 of 1960).

6. The Drugs (Amendment) Act, 1962 (21 of 1962).

7. The Drugs and Cosmetics (Amendment) Act, 1964 (13 of 1964).

8. The Drugs and Cosmetics (Amendment) Act, 1972 (19 of 1972).

9. The Drugs and Cosmetics (Amendment) Act, 1982 (68 of 1982).

[10th April, 1940]

It is hereby enacted as follows: -

1. Short title, extent and commencement -

2. Application of other laws not barred –

In this act, unless there is anything repugnant in the subject or context, --

(d) (Note: Clause (d) omitted by Act 19 of 1972, sec.3)

4. Presumption as to poisonous substances –

5. The Drugs Technical Advisory Board –

(ii) The Drugs Controller, India ex officio;

(iii) The Director of the Central Drugs Laboratory, Calcutta, ex-officio;

(vi) The President of the Medical Council of India, ex-officio;

(vii) The President of the Pharmacy Council of India, ex-officio;

(xii) One person to be nominated by the Central Government from the

(xv) One person to be elected by the Council of the Indian Pharmaceutical

6. The Central Drugs Laboratory –

(a) The functions of the Central Drugs Laboratory;

For the purposes of this Chapter, a drug shall be deemed to be misbranded, --

(a) If it is so coloured, coated, powdered or polished that damage is concealed or if

(b) If it is not labeled in the prescribed manner; or

(a) If it is imported under a name which belongs to another drug; or

(b) If it is an imitation of, or is a substitute for, another drug or resembles another

(c) If the label or container bears the name of an individual or company

(d) If it has been substituted wholly or in part by another drug or substance; or

(e) If it purports to be the product of a manufacturer of whom it is only truly a

(a) If it contains a colour which is not prescribed; or

(b) If it is not labeled in the prescribed manner; or

(a) If it is imported under a name which belongs to another cosmetic; or

(c) If the label or container bears the name of an individual or a company

(d) If it purports to be the product of a manufacturer of whom it is.]

10. Prohibition of import of certain drugs or cosmetics –

(Note: The Explanation omitted by Act 68 of 1982, sec.7 (w.e.f. 01.02.1983))

12. Power of Central Government to make rules –

(c) Prescribe, in respect of biological and organometallic compounds, the units or

(i) Prescribe the evidence to be supplied, whether by accompanying documents or

(1) Whoever himself or by any other person on his behalf imports, --

(a) Any drug deemed to be adulterated under section 9A or deemed to be a spurious

(2) Whoever having been convicted of an offence –

(Note: Subs. by Act 68 of 1982, sec.12, for "DRUGS" (w.e.f. 01.02.1983)).

For the purposes of this Chapter, a drug shall be deemed to be misbranded, -

(a) If it is so coloured, coated, powdered or polished that damage is concealed or if

(b) If it is not labeled in the prescribed manner; or

For the purposes of this Chapter, a drug shall be deemed to be adulterated, -

(a) If it consists in whole or in part, of any filthy, putrid or decomposed substance; or

(c) If its container is composed, in whole or in part, of any poisonous or deleterious

17B. Spurious drugs –